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OVERVIEW: VOLUME I 
 
This thesis is submitted for the degree of Doctorate of Clinical Psychology at the 
University of Birmingham.  It is presented in two volumes. Volume I includes a literature 
review, qualitative research paper and a public domain paper. The literature review uses a 
systematic review process to explore body image in children and young people with 
Inflammatory Bowel Disease (chronic, inflammatory intestinal conditions including Crohn‘s 
Disease, Ulcerative Colitis and Indeterminate Colitis). The original research is a qualitative 
paper, exploring the experiences of healthcare professionals working with children with a 
dual diagnosis of Type 1 Diabetes and Coeliac Disease. A public domain briefing paper is 
presented, which provides a summary of the literature review and qualitative paper, prepared 














OVERVIEW: VOLUME II 
 
Five Clinical Practice Reports are presented, which were completed during placements for the 
Clinical Psychology Doctorate.  
Clinical Practice Report 1: The case of a 13 year old boy with a severe learning disability is 
presented. The difficulties with his self-injurious behaviour are formulated from behavioural 
and systemic theoretical models. 
Clinical Practice Report 2: A service evaluation completed in a CAMHS team, auditing how 
the service was meeting the recommended criteria set in the NICE guidelines (2004) for self-
harm. 
Clinical Practice Report 3: A case study using a Cognitive Behavioural approach with a 29 
year old man, experiencing depression and anxiety, during an inpatient stay on an acute 
psychiatric ward.  
Clinical Practice Report 4: A single case experimental design based on the Newcastle 
Model, with a 74 year old man displaying behaviours that challenged on an older adult 
inpatient psychiatric ward.  
Clinical Practice Report 5: A case study using Acceptance and Commitment Therapy with a 
57 year old man, with low mood and adjustment difficulties in response to Chronic Kidney 
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Body image in young people with Inflammatory Bowel Disease:              
A systematic review 









Background: Inflammatory Bowel Disease (IBD) includes Crohn‘s Disease, Ulcerative 
Colitis and Indeterminate Colitis, all characterised by chronic, gastrointestinal inflammation. 
Symptoms can be painful and embarrassing and treatment can result in invasive procedures, 
side effects and surgery. Qualitative studies suggest that body image may be affected by IBD.  
Aim: To review published quantitative papers with a measure of body image in children and 
adolescents with IBD.  
Method: Electronic databases (PsycInfo, Embase, Medline, Web of Science, CINAHL) were 
used to systematically review the literature, identifying 19 papers. These papers were 
reviewed using a critical appraisal tool.   
Results: The review discusses themes relating to body image including: type of IBD 
diagnosis; age at diagnosis; severity of symptoms; gender and treatment. Trends in body 
image are similar to healthy peers, particularly for those with mild or no symptoms. IBD can 
predispose the young person to risk factors, increasing their vulnerability to poor body image, 
including delayed growth, increase in severe physical symptoms and intrusive or demanding 
treatments.  
Conclusion: Routine assessment of psychosocial factors, including body image, for young 
people with IBD is recommended. This review highlights methodological limitations in the 
current body of evidence, calling for further research to improve understanding of this area.  
Keywords: Inflammatory Bowel Disease, Crohn‟s Disease, Ulcerative Colitis, Indeterminate 




Inflammatory Bowel Disease 
Inflammatory Bowel Disease (IBD) is an umbrella term for idiopathic, chronic, 
inflammatory intestinal conditions. These encompass: Crohn‘s Disease (CD), Ulcerative 
Colitis (UC) and Indeterminate Colitis (IC). IBD presents as an intermittent disease, with 
symptoms that vary in severity during periods of relapse and remission, with approximately 
50% of patients experiencing relapse in any one year (IBD Standards Group, 2013). 
Symptoms of IBD are dependent on the phenotype of the disease and the section of the 
intestinal tract affected, however, symptoms typically include diarrhoea, constipation, 
incontinence, bowel movement urgency, abdominal pain, rectal bleeding, fever, loss of 
appetite and weight loss. Intestinal complications are associated with IBD, such as bleeding 
ulcers, bowel perforation, intra-abdominal abscesses, narrowing of the bowel, fistulas, 
perianal disease and an increased risk of colon cancer. IBD is additionally associated with 
extra-intestinal complications such as arthritis, osteoporosis and spondylitis (World 
Gastroenterology Organization, WGO, 2009). IBD is not to be confused with IBS (Irritable 
Bowel Syndrome); these are two separate diagnoses, with distinctly different aetiology, 
clinical presentations and treatment. 
There is no known cure for IBD. The British Society of Paediatric Gastroenterology 
Hepatology and Nutrition (BSPGHAN, 2008) outline the treatment goals in paediatric IBD, 
which are to bring the disease into remission, manage relapse, maintain good nutritional status 
and improve wellbeing. Treatment options include enteral nutrition1, corticosteroids, 
immunosuppressive agents and biological therapy. Surgery is also common, with 70-80% of 
                                                          
1
 A glossary of medical terms is provided in Appendix 1. 
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CD patients and 25-30% of UC patients requiring surgery in their lifetime (BSPGHAN, 2008; 
WGO, 2009). Treatment and management of IBD has improved in recent years, particularly 
with the introduction and licensing of biological therapies (such as Infliximab). These have 
been reported to significantly improve the course of treatment in IBD. Reported benefits 
include: inducing and maintaining remission, preventing complications, reducing 
corticosteroid exposure and reducing the need for surgery (Gould, 2013; Rutgeerts, Vermeire 
& Van Assche, 2009; McGinnis & Murray, 2008; Rungoe et al., 2013; Cassinotti, Ardizzone 
& Bianchi Porro, 2008; de Bie, Escher, & de Ridder, 2012). 
IBD can be diagnosed at any age; however, the peak age of onset is between 15-29 
years (Johnston & Logan, 2008). A prospective national survey of IBD in children under 16 
years in the UK found rates of 5.2 per 100,000 individuals per year, with a mean age at 
diagnosis of 11.9 years in under 16 year olds. Data suggest that only a small proportion of 
children are diagnosed under 5 years old (Sawczenko & Sandhu, 2003). A study by Van 
Limbergen et al. (2008) suggests that IBD diagnosed in childhood may involve a more severe 
disease course with more extensive intestinal involvement compared to adults. 
IBD associated complications 
Complications specific for young people stemming from IBD can include growth 
delay and delayed puberty, associated with under-nutrition, inflammation and steroid 
treatment (Shamir, Phillips & Levine, 2007). Growth delay is reported amongst all forms of 
IBD, but is most common in CD, with a prevalence rate of 40-50% in children affected 
(Cezard et al., 2002). Steroid treatments have a number of other associated side effects, 
including: ‗cushingoid‘ features (fatty deposits on the face causing roundness), reddish-purple 
stretch marks on the body and thinning of the skin. A ‗steroid hump‘ may develop, which is a 
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fatty deposit in the middle-upper back. Also redness of the face, facial hair growth, rapid 
weight gain and acne may occur. Guidance recommends against long-term steroid use in 
young people with IBD, however, it remains a widely used treatment, particularly in the 
induction of remission (BSPGHAN, 2008). 
In addition to the propensity for a more severe disease course in childhood, IBD 
presents young people with further challenges associated with developmental changes. 
Disease activity in IBD is linked to poorer psychosocial development, with a greater risk for 
depression, anxiety, poorer social functioning and lower self-esteem (Mackner, Crandall & 
Szigethy, 2006; Pinquart, 2012). Implications of the disease impact upon school life, leisure 
activity (Lindfred, Saalman, Nilsson, Sparud-Lundin & Lepp, 2012) and developing 
independence (Loonen, Grootenhuis, Last, Koopman & Derkx, 2002a). For children with 
chronic health conditions, the demands of their illness may also conflict with their developing 
social relationships, their desire to ‗fit in‘ and their self-image (Suris, Michaud & Viner, 
2004). 
Self-concept 
The mental perception we hold of ourselves is termed self-concept. Shavelson, Hubner 
and Stanton (1976) state that self-concept is influenced by our evaluations of academic, 
social, emotional and physical attributes. More recent research describes how the 
development of self-concept is influenced by expectations and judgments of others, genetic 
predisposition and interpersonal experiences (Bong & Skaalvik, 2003). Harter (1999) 
surmises that there is an abundance of terminology in the literature referring to the self, and 
draws attention to the distinction between global self-evaluations (such as self-concept) and 
domain-specific evaluations (such as physical appearance). 
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Childhood and adolescence is a phase of intense change, with emotional, cognitive, 
physical, behavioural and social transitions (American Psychological Association, 2002) all 
contributing to the individual‘s sense of self or self-concept. It is a time during which many 
young people strive to ‗fit in‘, whilst also shaping their personal identity and image. 
Body Image 
Identity and self-concept include a domain of physical appearance or body image.  
Body image has been theorised by Cash (2004) as the thoughts, feelings and behaviours of 
one‘s body-related self-perceptions and self-attitudes. It is considered to be a 
multidimensional construct (Banfield & McCabe, 2002), informed by historical, cultural, 
social, individual and biological factors. Changes in bodily appearance in young people can 
influence body satisfaction and self-esteem, with groups of adolescents who mature early and 
those who mature late being at risk of poorer self-evaluation, due to them not being in ‗the 
norm‘ group  (Williams & Currie, 2000). 
Adolescence is a time of increased self-consciousness (Sebastian, Burnett & 
Blakemore 2008). Therefore self-evaluation and comparison to others peaks during a period 
when sense of personal and social identity is rapidly forming. Festinger‘s Social Comparison 
Theory (SCT, 1954) can be used to offer insight into body image perceptions. The theory 
posits that individuals compare themselves to others and are also compared by others; 
similarities and differences are then used to evaluate their own standing. Body dissatisfaction 
has been reported to be higher for young people with chronic illness (Pinquart, 2013). Chronic 
illness and its treatments can often impact on physical appearance, and lead to restrictions on 
lifestyle, school attendance, social functioning (Michaud, Suris & Viner, 2007) and lower 
self-esteem (Pinquart, 2012). Increased body dissatisfaction in children with chronic illness 
can pose a high risk for engaging in unhealthy weight-loss practices (Neumark-Sztainer, 
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Story, Resnick, Garwick & Blum, 1995) and reduced self-care and dietary management 
compatible with their illness (Vlahou, Cohen, Woods, Lewis & Gold, 2008). 
Qualitative research on body image and IBD 
In a sample of 347 adults with IBD, 67% stated that having IBD impaired their body 
image. Body image was most affected in participants who were female and those that had 
undergone surgery (Muller, Prosser, Bampton, Mountifield & Andrews, 2010). Similarly, 
Brydolf & Segesten (1996) reported that young people with IBD have revealed feelings of 
being different (to their former self and peers), perceiving negative changes in their body 
image, embarrassment and diminished self-respect linked to diarrhoea and faecal 
incontinence. Furthermore, the authors found that dependency on being near a toilet and 
embarrassment of changing clothes around peers can restrict their activities. Nicholas et al. 
(2007) reported feelings of exclusion, vulnerability, illness uncertainty and lack of control in 
young people with IBD. Lack of control was specifically linked to their bodies, due to 
repetitive, intrusive investigations and violations of personal privacy. The authors found that 
adolescents with IBD have reported being more critical of their appearance than younger 
children, with boys having more concerns about their developing strength and height, and 
girls being more concerned about weight gain. Furthermore, adolescents viewed themselves in 
relation to perceptions they received from others, with many feeling their appearance was 
judged and criticised. Vlahou et al. (2008) found adolescent females with IBD were less 
satisfied with their bodies than males, and more positive body image was associated with 
better dietary self-management. A study looking at children and young adults following stoma 
surgery for IBD (surgically-created opening from the colon or intestine to the outside of the 
abdomen) revealed that despite generally positive results and good psychosocial adjustment, 
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patients had anxieties about leakage, noise, odour, social acceptability and sexual desirability 
(Lask, Jenkins, Nabarro & Booth, 1987).  
Existing literature reviews 
Body image of children within a range of nineteen chronic illnesses (including 
obesity, cystic fibrosis, scoliosis, cancer, diabetes, burns and kidney disease) has been 
reviewed using a meta-analysis of 330 studies (Pinquart, 2013), concluding that body image is 
reported as less positive than healthy children, but that the average effect size was small (g=-
.30 standard deviation units). The size of differences in body image was illness-specific; the 
strongest differences of body image were reported in obesity, cystic fibrosis and scoliosis (g=-
.79, g=-.50 and g=-.41 respectively). The authors suggest that this finding may be linked to 
these illnesses being visible to others; however, the moderating effect of treatments was not 
examined in this review. Since this review only included studies with active comparisons to 
healthy controls, only six studies of IBD were included. A small effect size (g=-.35) was 
found for the IBD sample, however a smaller sample was used compared to other illness 
samples (n=157) and the severity of disease activity was not reported. 
Mackner at al. (2006) conducted a systematic review of psychosocial function in 
paediatric IBD. This review concluded that children with IBD are at increased risk of 
psychosocial difficulties (i.e., symptoms of depression, anxiety, poorer social functioning and 
self-esteem), but these problems are only clinically significant in a small number of children. 
Body image (assessed within quality of life measures) was cited in six articles; however, due 
to conflicting results no conclusions regarding body image were drawn. In a systematic 
review of psychosocial functioning in paediatric IBD, Ross, Strachan, Russell and Wilson 
(2011) summarised that health-related quality of life (HRQoL) is lower amongst this group, 
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with an increased incidence of self-reported symptoms of depression and anxiety. However, 
more specific conclusions were limited due to methodological flaws across studies and 
conflicting evidence for associations with psychosocial functioning. From this review, the 
authors recommend that body image in IBD is an area of interest, which warrants further 
consideration.  
At the time of reporting, there has been no review of the literature specifically 
focussing on body image in children and adolescents with IBD. Body image and body 
dissatisfaction in the IBD literature is frequently found in HRQoL studies, of which there is a 
wealth of articles. This literature includes generic measures and disease specific measures to 
assess HRQoL, both of which have their strengths. Generic measures allow for comparisons 
with normative data, whereas disease-specific measures yield more sensitivity to aspects of 
health with regards to particular conditions (Wiebe, Guyatt, Weaver, Matijevic & Sidwell, 
2003). The IMPACT questionnaire is an IBD-specific measure, developed for young people 
aged 8-18 years (Griffiths et al., 1999). It includes a body image scale regarding satisfaction 
with height, weight and general appearance. The most newly developed version is the 
IMPACT III, developed by Otley et al. (2002).  
Summary and aims 
In summary, the consequences of the symptoms and treatments of IBD in children and 
adolescents can result in severe abdominal symptoms, invasive procedures, possible surgery 
and unpleasant treatment side effects. In addition to these challenges, under-nutrition and poor 
growth and development is associated with IBD. All of these factors contribute to 
psychosocial risk factors in the developing child. Chronic health conditions in childhood are 
posited to influence poorer body image perception in children and adolescents. Considering 
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the theories of body image, it seems plausible to hypothesise that IBD-related issues could 
serve as risk factors in the establishment of poorer body image in young people. There 
certainly exists a small body of qualitative research on this topic, previously discussed, which 
provides evidence for this hypothesis (Brydolf & Segesten, 1996; Lask et al., 1987; Nicholas 
et al., 2007; Vlahou et al., 2008).  However, at the time of reporting, no published systematic 
reviews exploring literature on body image in children with IBD is available.  Body image has 
been referred to as a factor of interest within the context of wider reviews on HRQoL in 
paediatric IBD; however the conclusions to date remain ambiguous. These reviews have 
included only small numbers of papers reporting on body image, too few for robust 
conclusions. There has also been an extensive period over which papers have been published. 
Older studies may not be representative of current experiences of young people with IBD, 
based on current treatments. In addition, previous reviews have not specifically reported body 
image findings in the context of factors such as severity of illness and age. 
Therefore the aims of this systematic review are to: 
 Assess and summarise the current body of evidence, which reports quantitative data on 
body image in young people with IBD. 
 Review the quality of the evidence of body image in young people with IBD. 
 Derive recommendations about how body image issues can be addressed in young 





Five electronic databases were used to search the literature; EMBASE (19742-2013 
December 19); MEDLINE (1946- December week 3, 2013), PsycINFO (1967 – December 
week 3, 2013), Web of Science (1960 – 19 December 2013) and CINAHL (1998 – 19 
December 2013). Search criteria included combinations of three elements: Body Image; 
Inflammatory Bowel Disease; and Child.  Terms were also searched using Medical Subject 
Headings (MeSH). Since the databases offered different MeSH terms, each database was 
interrogated to compile a thorough list of relevant search terms (Appendix 2). The ‗Tests and 
Measures‘ function on PsycINFO was additionally used to identify measures with a body 
image scale. Names of measures were added to the search if these were not already covered 












                                                          
2
 To gather the full breadth of papers on this topic for a thorough understanding of the 
published literature, initial searches included a broad timeframe. The date was then manually 
sorted according to the dates set in the inclusion criteria. 
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Table 1  
Inclusion and Exclusion criteria 
Inclusion Criteria Exclusion Criteria 
 Child self-report 
measure of body image. 
 Children aged 0-19 
years. 







 Quantitative data 
provided. 
 Original articles. 
 Articles published from 
19983 to present. 
 Do not include a child self-reported 
measure of body image. 
 Age of participants is over 19 years, or 
separate data on those participants 19 
or under is not provided. 
 Participants without a diagnosis of 
Inflammatory Bowel Disease.  
 Participants identified as having co-
morbidities with other chronic 
physical health problems. 
 Qualitative research design. 
 Not published in English language. 
 Papers published prior to 1998. 
 Not an original article (i.e. review, 
editorials, letters, conference abstracts 
or case studies).  
 
Additional papers of interest were found through the reference lists of articles 
obtained through the electronic search. Where papers did not report the scores of body 
image, the authors were contacted directly to request this information. In three cases, 
these data were not available; these three papers were identified as potential articles of 
interest, but could not be included in the review.  
Figure 2 shows the search strategy employed to elicit the final set of nineteen 
articles. A summary of the articles included is provided in Table 2. An index of 
measures is provided in Appendix 3, this provides the full name and a brief description 
of the measures stated in Table 2, which may be used as a reference guide. 
                                                          
3 This date marks the initial licensing and use of biological therapies, as detailed 



























Titles and abstracts identified and screened 
(limits applied for English Language, 
duplicate publications removed) 
n = 117 
Full copies retrieved and assessed for 
eligibility 
n= 68 
Publications that meet inclusion criteria 




Excluded n= 49 
- Not a journal article 
- Published prior to 1998 
 
Excluded n= 4 
Duplicate data reported 
 
Excluded n= 51 
Fails to meet criteria 
based on: 
- Primary diagnosis 
- No child self-report  
  measure 
- Age of participants 
- No quantitative   
  measure of body image 
- Raw data on body   
  image not available 
Included n = 6 
Studies identified from 























































- 92% inactive –
mild symptoms 




- 61% inactive 
- 31% mild and 
responding to 
treatment 













4 subscales with 
good-excellent 
reliability) 
- Elevated family 
functioning difficulties 
associated with lower 
HRQoL. 
 
- Body image mean score4: 
11.32 (2.41) 
 
- Significant associations 
between disease severity 
and all Impact scores (body 
image r= -0.32, p=0.01) 
 
Gray et al. add: 
- Internalising symptoms 
(social withdrawal, somatic 
complaints,  anxiety, 
depression) 
- Unrepresentative 
sample, predominance of 
inactive/mild status, CD, 
Caucasian and adolescent 
age, outpatient group. 
 




functioning at baseline. 
 
- Body image was not 
correlated with family 
functioning. 
 
- LCAI used as opposed 
to PUCAI for UC group. 
                                                          
4 Possible score range is between 3-15, with 15 representing more positive rating. 
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 strongly correlate with 
disease severity and 
predicted HRQoL. 
 
-Higher levels of 
externalising symptoms 
(behavioural problems and 
aggression) associated with 
lower HRQoL. 
 























since diagnosis and 
QOL in children 
with CD. To 
determine most 
significant 
predictions of QoL. 

















- Body image significantly 
higher in girls (t=3.09, 
p<0.01) 
 
- Age significantly related 
to body image (r=-0.26, 
p<0.01)). Increasing age 
associated with decreased 
body image 
 
- Height significantly 
related to body image 
(r=0.41, p<0.01)) 
 
- Disease activity 
significantly negatively 
correlated with QOL (Inc. 
body image p<0.01) 
 
 
- Small numbers in some 
treatment groups (enteral 
nutrition n=7, this group 
also had significantly 
higher disease activity & 
lowest height, weight and 
BMI scores). 
 
- Causal relationships 
difficult to assess. 
 
- Some data sets 
discussed but not 
provided in article e.g. 
shorter children had 
lower body image, QoL 
improved with increasing 
height Z score. 
 
 
                                                          
5 PCDAI disease severity classifications: ≤10 remission; 11-29 mild disease activity, ≥moderate-severe disease activity 
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Hill et al.  
continued 
- No significant association 
between body image and 
disease duration. Body 
image6  lowest for those 
diagnosed <6 months 
(10.6), improving to 11.7 
after 5 years. 
- Poorer body image for 
those receiving enteral 
nutrition (mean 10.1 (+-2.7, 
p<0.05), followed by 
immunosuppressant‘s + 
steroids (10.8 +-2.2, 
p<0.05)  









To obtain a profile 
of IBD related 
QOL. 
n=79, 9-17 years 
Male n=46 
CD n=41  












- Anxiety level significant 
predictor of QOL (p=0.001) 
 
- Qualitative measure:  
    Feelings of anger and  
    embarrassment. 
 
- Body image mean 3.567 
(SD 0.76) 
 
- IMPACT-III high internal 
reliability (alpha=0.90) 
 
- Qualitative feedback 
suggested wide 
variability in symptoms 
 
- Symptom severity not 
measured 
 
- Possible response bias 
(Postal measures) 
 
- Different scoring 
structure of IMPACT-III 
to other studies makes 
comparisons difficult. 
                                                          
6 Possible score range is between 3-15, with 15 representing more positive rating. 



















Impact of IBD on 
HRQOL using a 
generic and disease 
specific measure. 
IBD Group  
n= 83, 8-18 years 
CD n=41 
UC n=40 
IC n= 2 
Male n=45 
Disease activity:   
    mild n=50    
    moderate n= 19   
    severe n=12   
    unknown n=2 
Age (years):  
  8-11  n=18  
12-15: n=41  
16-18: n=24 
Postal recruitment 







Data taken from 
validation study of 
TNO-AZL (Vogels 












Body image mean 718 
        - CD 71 (+/- 22.8) 
        - UC 70 (+/- 20.3) 
 
-12-18 years groups had 
significantly impaired 
HRQOL on TACQOL 
compared to healthy peers. 
 
- Younger children (8-11 
years) had comparable QoL 
scores to healthy peers. 
 
- Impact-II (NL) 
discriminated well between 
patients in all age groups, 
with varying disease 
activity. 
 
- Body image significantly 
lower with increased 
disease activity (p<0.05) 
and increased disease 
severity (p<0.05). 
 
- Body image domain: 
cronbach‘s alpha 0.65 
(satisfactory). 
 
- Fewer children in the 
younger group, they also 
had lower symptom 
scores (11 had inactive or 
mild disease) 
 
- TACQOL has no body 
image scale; therefore 
this domain could not be 
compared. 
 
- Symptom Card is not a 
validated measure.  
 
- 7 week interval 
between test re-test. 
HRQoL may have 
changed within this time 
frame. 
 
- Responsiveness to 
change of IMPACT-II 
(NL) requires more 
vigorous testing in a 
longitudinal study 
design. 
                                                          



















children with IBD 
(in remission or 
mild disease 
activity) to healthy 
children 
IBD group  
n=50, 11-17 years 




Disease activity:  
   remission 62%  
   mild 32%  
   moderate-severe   


































- No significant difference  
  on self-concept scale. 
 
- 20% IBD group had  
  clinically significant   
  behavioural/emotional   
  symptoms (similar to   
  control group). 
 
Physical appearance scores9 
     IBD group 56.9 (9.97) 
     Healthy 58.1 (9.63) 
 
- No significant difference  
  between physical   
  appearance scores in IBD  
  and healthy group. 
 
- Mackner et al. (2005b)  
  add: better family  
  functioning and child  
  coping strategies correlate  
  with medication  
  adherence. 
 
Predominance of inactive 
mild disease status 





- PCDAI used for all IBD 
subtypes (this measure 
was developed for CD).  
                                                          
9 Piers Harris Self Concept Scale, T scores are provided with a mean of 50 and standard deviation of 10. T score lower than 34 is clinically significant. 
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To identify changes 
needed to adapt the 
IMPACT for use in 
British children 
with IBD and 
assess two versions 
of the scale. 
 
 
















with a VAS 
and one with a 
likert scale) 
Overall body image 
scores10: Likert scale =60, 
VAS =65. These scores 
were significantly different 
(p=0.01) 
 
- Body image scores were 
higher for males than 
females and higher for 8-12 
years age group than 13-16 
years on both versions of 
the scale. 
 
- The Likert scale was 
preferred by participants.  
- Further validation 
needed to ensure 
instrument is reliable and 
valid. Difference 
between scores on body 
image suggests 
unreliability of this 
domain. 
 
- Small sample, 
predominance of CD. 
 
- Details of recruitment 
were not provided. 
 
- Disease severity was 
not measured. Therefore 
representativeness of 
sample unknown. 






















Disease severity:   
   mild n=57  
   moderate n=120  











-IMPACT II  





- Significant improvements 
in HRQOL during the 12 
months from diagnosis 
(p<0.01).  
- Differences in body image 
scores11 from baseline to 12 
months not significant. 
Baseline 14.5 (4.6) 
6 months 15.3 (4.8) 
- Statistically significant 
changes reported, not 
clear if they are also 
clinically significant. 
 
- Some findings are 
discussed but the data are 
not reported. 
 
                                                          
10 Scores transformed to a 0 -100 scale, with higher scores representing more positive ratings. 
11 Based on a 7 point Likert scale, scores range from 3-21, with higher scores representing more positive ratings. 
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Otley et al. 
continued 
 
Data analysed from 
the ‗Pediatric IBD 




12 months 16.2 (5.1) 
 
- All other IMPACT 
domains showed significant 
change from baseline to 6 
months (p<0.01) 
 
- Disease severity did not 
reach statistical 
significance as independent 
variable for body image 
(p>0.05) 
 
- Only age was a significant 
predictor of HRQoL 1 year 
post diagnosis (p<0.01) 
- IMPACT was not 
consistently completed in 
close proximity of the 
disease activity 
assessment. 















Survey of children 
with IBD. 
 
Recruitment from 6 
gastroenterology 
centres in the US. 
Randomly recruited 
using numbers 
generated from a 
database. 
n=220, 8-17 years 
8-11 n=39 
12-15 n=94 









Recruited from 6 
No intervention. 
 







Body image mean scores12:    
       overall 68.1 (SD 19.6) 
      CD 67.9 
      UC 68.6. 
 
- Body image scores 
lower  
with higher disease  
activity. This was more 
significant in CD group 
(p<0.01) than UC (p=0.02) 
- Body image factor 
analysis revealed borderline 
- Symptom severity data 
not consistently collected 
at the same time as QoL 
data, this may have 
changed during the time 
period. 
 
- UC symptom data 
collected using a measure 
(UCS) with no previous 
use or validation.  
 
- Predominance of CD 
                                                          
12 Scores transformed to a 0 -100 scale, with higher scores representing more positive ratings.  
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based on statistical 
recommendations 
for factor analysis. 
acceptable reliability 
(0.63). Authors suggest 
adding additional body 
image items may improve 
reliability. 
and low disease activity 
in sample. 
 
- Participants not 
categorised into disease 












Coping styles of 
adolescents with 




style and HRQOL. 
IBD Group  
n= 65, 13-17 years 
Male n=45 
52% CD, 45%UC, 
3%IC 
Median disease 
severity: 8.5 (scale 




























- Adolescents with IBD use 
more avoidant coping styles 
than healthy peers 
(p<0.001).  
 
- HRQOL associated with 
disease related coping 
styles and disease activity.  
 
- Disease activity 
significantly associated 
with body image (p<0.05) 
 
- Coping styles not 
significantly associated 
with body image. 
 
- Raw scores for HRQoL 
domains not provided, 
comparison of body 
image scores with other 
studies was not possible. 
 
- CCSS-c was an 
invalidated measure at 
the time of use.Validated 
measures of disease 
symptom and severity 
not used. 
 
- Reference sample taken 
in 1994, may not be 
comparable to youth 9 
years later. 
 
- Postal recruitment with 
a 64% response rate. 










paediatric IBD in 
relation to physical 
activity compared 
to a healthy control 
group. 
IBD Group  











No chronic illness 
Matched for age 
and gender. 

















the IBD group 
and the 
KINDL for the 
control group. 
- Median body image 
score13 in IBD group: 80 
(60-87). No body image 
data from control group. 
 
- IBD and control group did 
not differ on overall QoL. 
 
-Trends: reduced levels of 
activity (p=0.058) and 
reduced steps (p=0.064) in 
IBD group. 
 
- IBD group = lower 
physical activity levels (not 
statistically significant.) 
 
- Reduced lean body mass 
in IBD group (p<0.05). 
- Armband suggested to 
overestimate low levels 
and underestimate high 
levels of activity- 
questioning reliability of 
results. 
 
- Design does not allow 
for conclusions regarding 
physical activity and 
QoL domains.   
 
- KINDL provides 
different domain scores, 
no body image scale, 
therefore IBD and 
control could not be 
compared on this 
measure. 
 
- Associations between 
lean body mass and body 
image were not explored. 
Intervention Studies (medical interventions) 





Change in QOL, 







- In 8 weeks, significant 
improvements were seen in 
QoL scores on all domains 
- Effect sizes are not 
provided. 
- No follow up to see if 
                                                          
13 Scores transformed into a 0-100 scale, higher scores indicate more positive rating. 
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Afzal et al. 
continued 
 
disease activity and 
intestinal status 









multiple UK sites at 
the point of 
diagnosis. 
(p<0.05).  
- More positive rating of 
body image14 was found 
following treatment 
(p<0.01)      
     Pre-treatment 52  
     Post-treatment 72  
 
-Clinical remission 
observed in 23 participants. 
effects were maintained. 
- Less generalisable to 
younger children. 
 
- Participants were 
enrolled at the point of 
diagnosis; it is not clear 
if the same treatment in 
patients further along 
their course in managing 



























n=14, 9-22 years 







n=10, 9-22 years 
CD n=9, UC n=1 
Male n=4 
 
Body image was 
only measured in 
Infliximab- 
biological therapy 
over 14 days. 





only used for 





are for this 
group.  
9-17 year age group: 
No significant difference 
between body image scores 
for symptomatic and 
asymptomatic group at 
baseline or Day 14. 
 
Symptomatic group: Body 
image15: Baseline 70.4,           
         Day 14: 71.7 (p=1.00) 
 
Asymptomatic group:  
Body image: Baseline 71.4, 
Day 14: 73.3 (p=0.67) 
Following treatment at day 
-PCDAI calculated only 
for patients with CD. 
 
-Groups assigned based 
on researcher questions 
rather than validated 
measure of symptoms. 
 
-Symptomatic group had 
mild symptoms only.  
 
-Some data discussed but 
not reported in article. 
 
-A longer follow up may 
                                                          
14 Scores transformed to a 0 -100 scale, with higher scores representing more positive ratings. 
15 Mean scores were converted in percentage scores.  
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DeBoer et al. 
continued 
the 9-17 years age 
group, 
demographics for 
this age group not 
provided. 
 
Recruited from US 
clinic, scheduled to 
start Infliximab. 
14, significant increases 
found in emotional 





be appropriate for QoL 
factors, 14 days is a 




such as serum and 
antibody levels of 
infliximab at baseline 
and follow up not 
assessed. 
 
-Unclear how many 
participants were in the 
9-17 year old age group.  




































mild n= 0  
moderate n=6 
severe n=27 
Details of current 
medication for each 
group provided. 
- IMPACT III  











and the IBDQ 
only in 
- No significant difference 
on Body image scores16 
between surgical and 
nonsurgical groups 
(p=0.54) 
      Nonsurgical 11.7 (2.6)  
      Surgical 11.3 (2.1) 
 
- No significant differences  
 on HRQoL for surgical and   
 nonsurgical group(p=0.09).  
 
- Higher QoL scores in  
 patients who are; in    
- Despite IMPACT being 
designed for under 18 
years, a separate measure 




- IBDQ used in patients 
aged 18; however this 
had no body image scale. 
 
-The two groups showed 
significant differences 
between; age (p<0.005); 
                                                          
16 Based on 5 point Likert scale. Subscale scores range from 3-15, with 15 representing a more positive rating. 
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mild n= 13 
moderate n=22 
severe n=20 
patients > 18 
years. 
 
 remission (p=0.05);   
 younger (P=0.06); lower   
 disease severity (p<0.001)  
 and less likely to be on  
 medication (P<0.05). 
 
- Females with higher QoL  
 had menses onset at  
 younger age (p<0.05), and  
 lower menstrual  
 irregularities (p=0.01). 
 
- Lower QoL in patients 
who had experienced 
weight loss (p<0.05). 
 
disease duration (p<0.05) 
and non-surgical group 
had significantly more 



















Pilot clinical trial, 
evaluating 















to reach participant 
number required.  
 
Recruitment from 
single US site. 
Opioid antagonist, 
Naltrexone for 8 
weeks, with a 
further 8 weeks of 
treatment as usual. 
 









- Significant reductions in 
disease activity after 
treatment (p<0.005). 
 
- Baseline mean body 
image score17: 
     Treatment group 10.7 
     Placebo group 10.8 
 
 
- No significant difference 
between baseline and 
treatment for body image. 
- Despite power 
calculations, it is a 
smaller sample. 
 
- Cross over design, 
therefore all participants 
knew to expect treatment 
during the study, which 




- 16 week data collection 
                                                          
17 Based on a 10 point Likert scale. Scores range from 0 to 21. With higher scores reflecting more positive ratings. 
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Smith et al. 
continued 
 
- Significant differences 
after treatment for systemic 
CD symptoms and social 
well-being (p<0.05)  
period is a small time 
period to allow for 
changes in HRQoL/ body 
image. 
- Recruitment details not 
provided, it is difficult to 
judge how representative 
the sample is. 
 





























baseline, 0-6 weeks 
post intervention 
and 6-8 months 
post intervention.   
Intervention Group 










n=18, 12-18 years 
Male n=6 
CD 61%: UC 22%; 
IC 17% 
 
IBD patients who 
Group intervention: 





-Role playing for     





 thinking & thought   
 challenging 
 






- Cognitive   
  Control    
  Strategies  
  Scale 




baseline 13.0,  
     post intervention 
15.5 
Control: baseline 13.4, 
post intervention 13.8 
 
 Dux-25 body image 
mean scores19: 
Intervention group: 
baseline 55.4, post 
intervention 68.9 
Control: baseline 60.0, 
post intervention 59.0. 




-Response rate of 46%, 
may suggest response 
bias, those more 
proactive in receiving 
support took part or those 
faring better chose not to 
take part?  
 
-Relatively small sample 
size and dropout rate 
(n=8) at follow up. 
Participants who dropped 
out had better baseline 
                                                          
18 SPAA physical appearance, possible score range 6- 24 
19






lived too far away 
to participate in 
intervention served 
as the control. No 
significant 
demographic, 




not provided. -6-8 months post 
intervention,  physical 
appearance more positive 
(p<0.01) & body image 




correlated with physical 





correlated highly with 




highly with HRQoL (0.77*) 
and anxiety (-0.63*). 
 
-Social functioning, 









emotional functioning.  
 
-SPAA- not an accurate 
measure for children with 
chronic illness (Aasland 
& Diseth, 1999)  
 
-Disease activity and 
severity not monitored. 
 
-Dux-25(QoL 














analysis of HRQoL 
in children and 
adolescents with 
IBD attending an 
IBD summer camp. 
n= 61, 9-16 years 




recruited from IBD 
camp. 
 
Week long IBD 










on first and 
last day of 
camp. 
- Overall body image 
scores20 showed small 
(non-significant) 
improvements post camp: 
Pre-camp: 12.6 
Post-camp: 13.2 
- All age groups showed 
small improvements in 
body image scores, apart 
from the 15-16 year group.  
 
- Total QOL, Social 
functioning, bowel 
symptoms, treatment and 
interventions showed 
significant differences pre 
and post camp (p<0.05). 
- Clinical significance of 
results not indicated 
 
- Not all participants 
returned questionnaires, 
possible sample bias. 
 
- Large sex differences in 
sample. No disease 
severity measure, 
minimal characteristics 
of sample provided. 
 
- Those attending the 
camp may be more 
inclined to actively seek 
information and support 
than other IBD patients. 
 
Evaluation of Psychometric Properties 


















Diagnosed for >6 
months 






Mean Body image score21: 
77.1 
- Inactive symptoms: 78 
- Mild: 76.6 
- Moderate-severe: 71.9 
 
Body image domain- 
Body image subscale in 




Possibility of sample bias 
in those who returned the 
                                                          
20 Based on a 10 point Likert scale. Scores range from 0 to 21. With higher scores reflecting more positive ratings. 
21 Scores transformed to a 0 -100 scale, with higher scores representing more positive ratings. 
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internal reliability (0.64). 
 
HRQoL score highest for 
quiescent IBD, significantly 





























and validation of 
MMQL-UK to 





Care, IBD and 
healthy controls. 





















- Physical appearance mean 
score22 IBD=67.8,   
            Control=69.8 
 
- Physical appearance range   
            61.5 (cancer) to     
            77.1 (Diabetes). 
 
- Appearance scale score 
lower (not significantly) 
than control group for all 
conditions others than 
diabetes. 
 
- Compared to control 
group, none of chronic 
condition groups scored 
significantly different on 
physical appearance. 
 
- Demographics not 
provided. 
 
- Little detail on 
inclusion/ exclusion 
criteria and recruitment. 
 
- Differences within 
chronic condition groups 
were not reported e.g. 
variable such as disease 
severity, treatment 
                                                          





- Adaptations were made to 
the MMQL to increase 
suitability for UK children. 
 
- Good internal reliability 
found for all components of 






















































- Body image mean score  
   9.823 (+/-3.1) 
 
- Positive correlation:  
  disease duration and QoL  
  (p<0.05) 
- Negative correlation:  
  disease activity and QoL  
  (p<0.05) 
- No difficulties in 
interpretation of body 
image questions.  
 
- Moderate to strong 
negative correlation 
between PCDAI and 
HRQOL (p<0.05) 
 
Qualitative feedback:  
-Visual reminders of CD 
- Small sample size. 
  
- Possible selection bias.  
- Possible bias in 
response: Half completed 
questionnaires via post, 
half came to clinic and 
met with the researcher. 
 
- Disease severity scores 
taken from most recent 
outpatient appointments. 
Length of time since 
these differed, therefore 
could affect validity. 
 
- Data not provided for 
associations between 
body image and: age; 
disease duration; 
                                                          
23 Possible score range is between 3-15, with 15 representing more positive rating. 
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Lowe et al. 
continued 
(e.g. 3) caused 
embarrassment.  
- Not knowing others with 
IBD 
 - Treatment regimen tiring 





Description of Studies 
The publication date of studies included in the review ranges from 2002-2013. The 
countries of origin include Croatia (1), United States (8), United Kingdom (4), Netherlands 
(3), Australia (1), New Zealand (1) and Germany (1). The age ranges of participants were 7-
19 years; all included both male and female participants. The majority of the studies included 
a mixture of IBD diagnosis (14), however, in the remaining studies, exclusive diagnoses of 
CD (4) and UC (1) were investigated. All of the participants were drawn from clinical 
populations, recruited from the IBD database at their clinic or hospital (18), or from an IBD 
register (1).  The question of how representative these samples were on the basis of diagnosis 
can be addressed in terms of the distribution across diagnostic categories. The most prevalent 
of the IBDs is CD, followed by UC, with IC seen in much fewer cases. This trend was 
reflected in 6 of the 14 studies that reported a mix of IBD diagnoses. 
The details provided on the diagnosis or confirmation of IBD were varied. The 
inclusion of participants with a diagnosis according to the criteria provided by ESPGHAN 
(European Society of Paediatric Gastroenterology, Hepatology and Nutrition) was specified in 
one study; one study stated that diagnosis was verified by endoscopic or radiographic reports; 
and one study included participants from the point of their diagnosis with gastrointestinal 
endoscopy, ilieo-colonoscopy and barium meal. Fifteen studies stated that participants had a 
confirmed diagnosis of IBD, and one study assumed diagnosis from the participants being 
members of a Crohn‘s specific organisation. Two studies included participants specifically 
from the point of diagnosis; one study looked at those diagnosed for less than 6 months; four 
stated their participants had been diagnosed for more than 6 months; five reported an average 
disease duration between 1-3 years; three reported an average duration of over 3 years and 
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four did not include details. Mostly, studies measured and reported the symptom severity of 
their sample; six studies included inactive/mild symptoms; six studies included a mix of 
symptom severity; two reported moderate-severe symptoms; and four studies did not specify 
or did not measure this factor. 
The primary aim of ten of the studies was to investigate HRQoL in children and 
adolescents with IBD, while four papers assessed outcomes or effectiveness of a medical 
intervention (enteral nutrition, biological therapy, opioid receptor antagonist and surgery), two 
papers measured outcomes of non-medical interventions (IBD camp, CBT group) and three 
were evaluations of the psychometric properties of measures. 
In this review, body image was measured by the body image scale of the IMPACT 
questionnaire in 16 studies. The remaining studies used generic, non-illness-specific 
measures, including the physical appearance scale of the Piers Harris Self Perception Scale 
(PHSCS, Piers, 1996), the body image scale of the Minneapolis-Manchester Quality of Life 
Instrument (MMQL-UK, Bhatia et al., 2002), and the physical appearance scale of the Self 
Perception Profile (Harter, 1988). All are standardised quantitative measures. 
Body Image Scores 
Despite the predominant use of the IMPACT questionnaire, there are different 
versions of the questionnaire, which differ in scoring methods and limit the ease of 
comparability. The majority of authors transformed the IMPACT scores onto a scale of 0-100 
(Abdovic et al., 2013; Afzal et al., 2004, Loonen et al., 2002a; Ogden et al., 2008; Perrin et 
al., 2008; Werksetter et al., 2012). These papers reported a range of body image scores from 
52 to 80, with most scores falling in the 70‘s. 
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Four papers used the IMPACT III  (Otley et al., 2006) with a five-point Likert scale, 
reporting the overall mean in the sample from the sum of the three body image questions 
(Herzer et al., 2011; Hill et al., 2010; Lowe et al., 2012; Malik et al., 2013). With a possible 
score range from 3-15, scores reported in these papers range from 9.8 to 11.7. 
Two papers used the IMPACT II (Loonen et al., 2002a), with a seven-point scale, 
using the same scoring system denoted above for the IMPACT III, but with a possible score 
range from 3-21 (Otley et al., 2006; Shepanski et al., 2005). Scores reported in these papers 
range from 12.6 to 16.2. 
Kilroy et al. (2011) reported a mean score of 3.6 from the five-point Likert scale, with 
1 being the most problematic to 5 being the least problematic. Due to the IMPACT being a 
disease specific measure, no healthy control group could complete the questionnaire for 
comparability. Despite the measure being used with different scoring systems, all of the 
findings reported above reveal body image scores which fall within the top third of the 
possible scoring range.  
The PHSCS is a generic measure including a physical appearance scale. Mackner and 
Crandall (2005a) employed this measure and found no significant difference between physical 
appearance in the IBD group and a healthy control group (56.9 and 58.1 respectively). A T-
score lower than 34 is suggested as clinically significant on this measure. The Self Perception 
Profile for Adolescents (SPPA, Harter, 1988) used in Grootenhuis et al. (2009) study, yields a 
score range on the physical appearance scale of between 6 to 24. At baseline the IBD group 
scored a mean of 13, followed by a statistically significant increase to 15.5 following a CBT 
group intervention.  Physical appearance for an IBD group measured by the MMQL-UK 
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(Hutchings et al., 2007) revealed a score that was comparable to other chronic illnesses, but 
lower than that of a healthy control group (however this was not statistically significant).  
Quality Review Framework 
The framework presented by Caldwell, Henshaw and Taylor (2005) was chosen to 
review this body of literature (see Figure 2). This framework was designed for critiquing 
health-related research. The framework states the criteria for critique, however for additional 
clarity and detail, a numerical scale was added to the framework for this review. Each criteria 
of the framework was assessed according to a 0, 1 or 2 point system; where 0 conveys no 
evidence or that the criteria was unmet; 1 conveys partial evidence for meeting the criteria; 
and 2 reflects that the criteria had been sufficiently met. Detailed published guidelines were 
followed in applying each stage of the quality framework (Caldwell, Henshaw & Taylor, 
2011). Additionally, one of the criterion ‗Are the authors credible?‘ was excluded, since it 
was felt that the quality and plausibility of a piece of research should not be judged on 
author‘s credentials having been provided.  
Inter-rater reliability checks on the quality review scoring process were performed to 
independently assess for risk of bias. The researcher‘s academic supervisor chose three of the 
final articles at random, and completed a blind quality rating using the quality review 
framework. A high level of agreement was found between the researchers and supervisors 
scores, which promotes reliability in the final scores assigned. This process was discussed in 
supervision following the inter-rater reliability checks, with both supervisor and researcher 
justifying why scores were assigned for each article. The researcher then reviewed the quality 



















 Quantitative Quality Review Framework  
1. Does the title reflect 
the content? 
 
2. Does the abstract 
summarize the key 
components? 
 
3. Is the rationale for 
undertaking the research 
clearly outlined? 
 




5. Is the aim of the 
research clearly stated? 
 
6. Are all ethical issues 
identified and addressed? 
 
7. Is the methodology 
identified and justifiable? 
 
8. Is the study design 
clearly identified, and is 
the rationale for choice of 
design evident? 
9. Is there an experimental 
hypothesis clearly stated? 
Are the key variables 
clearly defined? 
 
10. Is the population 
identified? 
 
11. Is the sample 
adequately described and 
reflective of the 
population? 
 
12. Is the method of data 
collection valid and 
reliable? 
 
13. Is the method of data 
analysis valid and 
reliable? 
 
14. Are the results 
presented in a way that is 
appropriate and clear? 
 
15. Is the discussion 
comprehensive? 
 
16. Are the results 
generalisable? 
 









                                                          





























































































































































































Afzal et al. (2004) 2 2 2 1 2 1 2 1 1 2 2 2 2 2 2 1 2 29 
Otley et al. (2006) 2 2 2 2 2 1 2 2 1 1 2 1 2 1 2 2 2 29 
Perrin et al. (2008) 1 2 2 2 2 1 2 1 2 2 2 1 2 2 2 1 2 29 
Smith et al. (2013) 1 2 2 2 2 2 2 2 0 2 1 2 2 2 2 1 2 29 
Loonen et al (2002a) 2 2 2 2 2 1 2 1 0 2 2 1 2 2 2 2 1 28 
Herzer et al. (2011) 2 2 2 2 2 1 1 1 2 2 1 1 2 1 2 1 2 27 
Mackner & Crandall 
(2005a) 
2 2 2 1 2 1 2 2 0 2 1 1 2 2 2 1 2 27 
Malik et al. (2013). 2 2 2 2 2 1 2 2 0 2 1 1 2 2 2 1 1 27 
Grootenhuis et al., 
(2009) 
2 2 2 2 2 0 2 1 1 2 1 1 2 2 2 1 2 27 































































































































































































Van der Zaag-Loonen 
et al. (2004) 
2 1 2 2 2 2 1 1 2 1 2 1 2 1 2 1 1 26 
Abdovic et al. (2013) 2 2 2 1 2 1 1 1 0 2 2 1 2 2 2 1 2 26 
DeBoer et al. (2012) 2 2 2 1 2 1 2 1 2 2 1 1 2 1 2 1 1 26 
Hill et al. (2010) 1 2 2 1 2 1 2 2 0 2 1 2 2 1 2 1 1 25 
Shepanski et al. 
(2005) 
2 2 2 2 2 1 1 1 0 1 1 1 1 2 2 1 1 23 
Werkstetter et al.  
(2012) 
2 2 1 1 2 1 1 1 1 2 1 1 2 1 2 1 1 23 
Hutchings et al. 
(2007) 
1 2 2 1 2 1 2 1 0 1 1 1 1 1 1 1 1 20 
Ogden et al. (2008) 2 1 2 1 2 1 1 1 0 1 1 1 1 2 1 1 1 20 
Lowe et al. (2012) 2 2 2 1 2 1 0 0 0 1 1 1 1 1 2 1 1 19 
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Strengths in the articles are visually represented by the scoring and colour coded system in 
Table 2.  The articles generally provided a good literature review, rationale, descriptions of 
methodology and succinct discussions. The rationale for design choice was less well 
discussed. All of the articles used clinical populations, which were generally representative of 
IBD populations; however, generalisability of samples could be influenced by sampling bias, 
based on those who chose to take part. Across studies, good descriptions of inclusion and 
exclusion criteria for the population were mostly reported. Flaws were also evident in data 
collection methods, since valid symptom severity measures and control over data collection 
variables were not consistently evident.  
The critical appraisal scoring system used in Table 2 yields a maximum score of 34. 
For the purpose of identifying the strongest articles to base conclusions on within this review, 
articles scoring between 24- 34 are considered to be of higher quality. This cut-off was 
decided based on visual analysis of the quality scores in Table 2; those below the cut-off have 




THEMES ASSOCIATED WITH BODY IMAGE 
In addition to scores of body image, the articles reviewed also revealed a number of 
themes which were associated with body image. These include; symptom severity; age, 
gender; diagnostic categorisation; duration of illness; and treatment. These themes were 
derived from either the main focus of the article or from the results reported. These themes 
and the reported findings will now be discussed.  
Symptom Severity 
The most widely reported factors associated with body image in these papers were 
those of symptom severity and disease activity. There was a strong association between 
higher disease severity and poorer body image (Abdovic et al., 2013; Herzer et al., 2011; Hill 
et al., 2010; Loonen et al., 2002a; Perrin et al., 2008; Van der Zaag-Loonen et al., 2004). 
Lower QoL was also associated with increased disease severity (Afzal et al., 2004; DeBoer et 
al., 2012; Malik et al., 2013; Otley et al., 2006). This finding was found amongst the higher 
quality papers in this study, which adds weight to the conclusion that this is a strong 
relationship. 
The association between increased disease severity and poorer body image is 
supported by studies that have compared participants with mild disease severity to those in 
remission. DeBoer et al. (2012) observed no significant difference in body image scores 
between those in remission and those with mild symptoms. Mackner and Crandall (2005a) 
reported few differences in psychosocial outcomes between those in remission and healthy 
controls. It can be concluded that it is not valid to combine data concerning body image of 





Age was found to be significantly related to body image, with increasing age 
associated with decreased body image in children with IBD (Hill et al., 2010). Otley et al. 
(2006) purport a decrease in QoL domain scores by five points for every additional year of 
age and reported that this trend was also evident on the body image scale (however these data 
were not reported). Loonen et al. (2002a) reported data on separate age groups, observing 
comparable QoL scores to healthy peers in 8-11 year olds, and significantly impaired QoL 
scores in older children in 12-18 years age group. This is evidence of psychosocial changes 
with increased age; unfortunately the QoL measure used for the healthy controls did not 
include a measure of body image, and therefore the two groups could not be specifically 
compared in aspect of body image. Despite the paper receiving a lower quality score, this 
finding was also found in Ogden et al. (2008), who showed that body image score was higher 
in the 8-12 year group than the 13 -16 year group. 
Additional evidence provided by Malik et al., (2013) relates the age of diagnosis to 
HRQoL. This study found significantly increased QoL in females who had begun menses at a 
younger age (ages not specified) and those who had less menstrual abnormalities.  For 
females, if symptoms of IBD and health complications influence or delay their physical 
development, this may be an influential factor for psychosocial difficulties.  
These age trends would also be expected in healthy children (Muris, Meesters & Fijen, 
2003). The transition through puberty can intensify body image concerns, which is associated 
with reduced self-esteem and self-worth (Croll, 2005). However, contrary evidence in a recent 
longitudinal study of young people in the UK, found body satisfaction to remain stable and 
positive during four years of adolescence (Morin et al., 2011). 
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Based on the stronger papers in the review, Loonen et al. (2002a) and Hill et al. (2010) 
highlight that increased age (specifically the 12-18 year old group) is associated with poorer 
body image compared to younger age groups (8-11 year olds). The evidence suggests that 
children and adolescents with IBD experience similar scores in body image to their healthy 
peers at younger ages. Despite following similar trends to healthy peers in terms of increased 
body image concerns during adolescent years for those with IBD, body image concerns may 
be exacerbated or hindered for those with IBD related complications e.g. delayed or 
problematic menstrual cycles in girls.  
Gender 
Despite both sexes reporting body image concerns, healthy females are liable to report 
lower body satisfaction than healthy males (Burrowes, 2013). In this review, body image 
scores were higher for males than females in Ogden et al. (2008), however, levels of 
significance were not reported and this paper yielded a low quality review score. According to 
Hill et al. (2010) body image scores were significantly higher in girls. Despite a significant 
result, this should be considered with caution since the study had a gender split of 32:9 (male: 
female) and the sample featured a mean symptom severity score in the mild range.  Hill et al. 
also found that body image was significantly related to height; this may explain the gender 
body image differences in the study, since research has shown that body satisfaction in 
adolescent males is associated with strength and height in IBD groups (Nicholas, Otley, Smith 
et al., 2007) and healthy peers (McCabe & Ricciardelli, 2004). 
There is conflicting evidence regarding gender differences and body image. However 
despite the lower ratio of females in Hill‘s study, this paper was rated a higher quality score 
and had specifically defined groups (i.e. all CD, mild disease activity, specified data for ages 
was provided). Based on the available data, it seems likely that differences in body image 
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between genders follow similar trends to healthy peers, in terms of delays in growth and 
height influencing body image of boys.  
Diagnostic categorisation 
In relation to other chronic illnesses, Hutchings et al. (2007) found physical 
appearance scores for children and adolescents with IBD and other chronic illnesses to be 
lower than the control group (apart from diabetes, scoring higher). However, in none of the 
chronic conditions were scores significantly different from healthy peers. This article scored a 
low quality score, largely due to insufficient demographic and methodological details 
provided in the paper. However, it does appear to support findings by Pinquart (2013) and 
Mackner et al. (2006), reporting small differences in body image and psychosocial factors 
between chronic illnesses (including IBD) and healthy peers. 
There are differences in the symptoms and management of the types of inflammatory 
bowel diseases under the umbrella term IBD.  While UC leads to inflammation of the inner 
lining of the colon, CD can affect any section of the digestive tract from mouth to anus, and 
inflammation can occur in all layers of the bowel walls (Crohn‘s and Colitis UK, 2011). 
Differences can include greater propensity for rectal bleeding in UC (which is uncommon in 
CD), whereas strictures, fistulas and fissures (restrictions, cavities or tears) are more common 
in CD, along with the development of an abdominal mass. In severe cases, surgery for UC 
will include complete removal of the colon (colectomy), with the surgical creation of an 
internal pouch (ileostomy) made from healthy small intestine; in some cases this is considered 
a ‗cure‘. However, due to the wider spread of affected tissue, surgery in CD seeks to preserve 
as much tissue as possible. Sections of diseased tissue may be removed, connecting remaining 
healthy sections. In cases of colectomy, internal pouches are not an option, due to the risk of 
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CD occurring in the pouch, leading to a stoma and external pouch. It is possible that these 
differences between CD and UC could affect both physical health and psychosocial outcomes, 
and therefore diagnostic categorisation is a confounding variable in IBD research. Individuals 
with IBD have an increased risk of developing colorectal cancer, which increases the longer 
the duration one has the disease (Bernstein, Blanchard, Kliewer & Wajda, 2001). Mortality 
from IBD has declined over the past 50 years; more recent mortality trends show similarities 
between UC and CD (Sonnenberg, 2007), with an increased mortality rate (0.5% per year) in 
IBD patients compared to the general population (Card, Hubbard & Logan, 2003). 
A level of significance for the association between poorer body image and increased 
disease severity was reported in CD than UC (Perrin et al., 2008), however, Loonen et al. 
(2002a) found almost the same body image scores for CD and UC patients; and Kilroy et al. 
(2011) did not find that type of IBD was a significant predictor of HRQoL. Five of the 19 
studies specifically included only one type of IBD in their sample (Afzal et al., 2004; Hill et 
al. 2010; Smith et al., 2013; Malik et al. 2013, Lowe et al. 2012), however under inspection, 
the body image scores from these studies appear consistent with those from studies using 
mixed diagnoses. There was no evidence in this review to conclude that the type of 
inflammatory bowel disease was associated with differences in body image. 
Duration of Illness 
The characteristically intermittent nature of IBD can make it an unpredictable illness 
to manage, with patients often passing between periods of relapse and remission during the 
natural course of the condition. Otley et al. (2006) found that body image scores increased 
from the point of diagnosis up to 12 months post-diagnosis, however, results were not 
statistically significant. In a five-year study, Hill et al. (2010) did not find any link between 
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the time since diagnosis and body image, however Otley et al‘s  study had a much larger 
sample than Hill et al‘s and included more participants with greater disease severity. 
There is uncertainty in the evidence for the influence of time since diagnosis on body 
image. Otley et al‘s study suggests that poorer body image is found at the point of diagnosis, 
and may improve during the following year. This hypothesis is linked to symptom severity, 
with children experiencing more severe symptoms at the point of diagnosis, which decrease 
once treatments are commenced and remission is brought about. However, due to lack of 
statistically significant data, no firm conclusion can be drawn. Given the intermittent nature of 
IBD over time, there is potential for individuals to learn more and develop their understanding 
of the implications of IBD and possibly experience further relapse and complications as time 
goes on. 
Treatment 
Medical trials and effectiveness studies have included psychosocial elements 
alongside medical evaluations. Significant improvements in body image were found after 
treatment with enteral nutrition for eight weeks (Afzal et al., 2004). Some improvements in 
body image (not reaching statistical significance) were observed after biological therapy for 
fourteen days (DeBoer et al., 2012) and no changes in body image were reported after 
treatment with an opioid antagonist over 16 weeks (Smith et al., 2013). These points raise the 
question of the mechanism by which body image could be being influenced and how long it 
would take to influence this concept.  Improved quality of life and decreased symptoms may 
be observed in fourteen days; however a longer period of time may be required for changes to 
translate to concepts such as body image.  
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Malik et al. (2013) add an interesting element to the review by exploring the impact of 
surgical interventions in UC. These data suggest that body image is lower for the surgical 
groups (however this did not reach statistical significance, perhaps due to significant 
differences between the two groups, with the non-surgical group experiencing greater 
symptoms). It would not be surprising to find changes in body image in surgical groups, 
which could be interpreted in light of surgical patients having an increase in invasive 
procedures performed, physical changes and scarring brought about from surgery (for 
intestine resection, colectomy or to treat abscesses or fistulas) and possible changes in shape 
through weight loss or weight gain post-surgery. This study showed that quality of life is 
higher amongst patients not taking medication, indicating that treatment regimes may also 
influence psychosocial factors. This is supported by Hill et al. (2010) who found significantly 
poorer ratings of body image for those taking enteral nutrition, followed by 
immunosuppressants plus steroids compared to patients taking other IBD medications (both 
of these treatment groups had lower mean body image scores than the surgical group in Malik 
et al. 2013). 
Psychosocial interventions included a group CBT intervention (Grootenhuis et al., 
2005) and a one-week IBD summer camp (Shepanski et al., 2005). The CBT group boasted 
significant improvements in body image, which were maintained at the 6-8 month follow up. 
The camp did not show changes for body image, but did have changes for overall QoL and 
social functioning. Again, one week for the follow-up in Shepanski et al. may not have been 
long enough to influence change for body image, and this study has a number of 
methodological flaws.  
This evidence suggests that the type of treatment may be influential in perceived body 
image. Treatments that bring about remission and alleviation of symptoms may aid 
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improvement in body image; however some treatments are also associated with poorer body 
image. The causal factor is not clear from these studies, it could be hypothesised that the long 
term regimes, dietary management and side effects involved in some medications may have a 
negative influence, however since other variables were not controlled in the studies, no firm 
conclusion can be drawn. Psychological support, such as the group intervention in 
Grootenhuis et al. (2009), has been shown to improve body image via a process of 
psychoeducation, relaxation and CBT based exercises.  
Additional Psychological Factors 
There were psychological factors of interest highlighted in the review, which may be 
linked to body image or self-perception. It was posited that autonomy, motor functioning and 
emotions are affected in adolescents with IBD (Loonen et al., 2002a); these factors could play 
a role in the development of the adolescent‘s sense of self and natural progression of gaining 
independence. Higher internalising complaints (social withdrawal, somatic complaints,  
anxiety and depression) and social problems were reported for children with IBD compared to 
healthy peers and a marked difference was found in boys (DeBoer et al., 2005). High 
correlations were found between social functioning, physical appearance, self-esteem, 
internalising, externalising (behavioural problems and aggression) and total behavioural 
problems. Furthermore, clinically elevated family dysfunction in IBD families (Herzer et al., 
2011) may be a factor which influences emotional and self-development.  
Differences in children and adolescents‘ coping styles emerged as significantly 
different to healthy peers in this review. Mackner and Crandall (2005b) reported a higher 
occurrence of ‗wishful thinking‘, and avoidant coping styles were observed by van der Zaag 
Loonen et al. (2004). Avoidant style may correspond to the embarrassment expressed by 
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young people with IBD and attempts to conceal their illness, symptoms and treatment. Meijer, 
Sinnema, Bijstra, Mellenbergh and Wolters (2002) found that avoidance was not a strong 
predictor of psychosocial adjustment in adolescents with chronic illness and reported that 
active coping methods are preferable to passive coping (including avoidance and depressive 
coping behaviours).  
It was suggested that a diagnosis of IBD prior to the onset of puberty might have 
fewer negative psychosocial consequences than a diagnosis during puberty, since females 
who had menses at a younger age had significantly higher HRQoL and fewer menstrual 
irregularities (Malik et al., 2013). This concurs with previous studies regarding the benefit for 
adolescents who develop at the same time as the majority of their peers, fitting into the 
developmental ‗norm‘ (Williams & Currie, 2000) and influencing how the young person 
perceives their body. 
The review revealed clinically relevant data, showing that young people with IBD 
adjust their lifestyle, doing less activity and resting more than their healthy peers even in 
periods of remission (Werksetter et al., 2012). The authors described the role of physical 
activity in building and maintaining healthy musculature, which may be lacking in children 
with IBD, which in turn, based on the evidence particularly for adolescent males with IBD, 
could influence self-esteem and body image.  
In conclusion, the trends in body image reported for children and adolescents with 
IBD appear to follow similar patterns as their healthy peers, particularly for those in remission 
or with only mild symptoms. However, the nature of IBD may present the young person with 
a range of risk factors, which in turn has the potential to increase their vulnerability to poor 
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body image. These include delayed growth or height, and increase in severe physical 



















METHODOLOGICAL QUALITY AND RESEARCH FINDINGS 
This is the first systematic review to explicitly assess body image in children and 
adolescents with IBD. There were a number of flaws within the body of evidence, which limit 
the strengths of conclusions on this topic, and warrant further research to address these 
aspects and offer more robust findings.  
Firstly, no specific measures of body image were found in the literature for children or 
adolescents with IBD, therefore conclusions are reliant on body image and physical 
appearance scales based within broader quality of life measures. The IMPACT questionnaire 
is most commonly used to report on body image, however since this only includes 3 items, a 
more detailed body image questionnaire may be more informative. Despite the overall high 
internal reliability on the IMPACT questionnaire, the body image scale has been called into 
question. Abdovic et al. (2013), Loonen et al. (2002a) and Perrin et al. (2008) found 
borderline to satisfactory acceptability on the body image scale. Perrin et al. (2008) suggest 
the addition of items to this domain to increase reliability. Additionally, since this is a 
disease-specific measure, no comparison group or normative data are available. This is 
particularly pertinent, since one of the fundamental questions that remains unclear, is whether 
body image in children with IBD differs from the body image concerns reported in healthy 
young people.  
Alongside a measure of body image which would allow for comparison with healthy 
controls, future research would also benefit from a longitudinal design to examine changes 
over time and the long term influences of IBD on body image, and to assess body image in 




It is also important that severity of symptoms is measured and reported with an 
appropriate measure for the disease type, such as the PCDAI (Hyams et al., 1991) for CD and 
PUCAI (Turner et al., 2007) for UC, since severity of symptoms is a confounding variable, 
which is not consistently reported. The significance of accurately measuring and recording the 
severity of symptoms should also be noted, with validated measures such as. The current 
research has demonstrated the need for interpretation of body image data based on inactive, 
mild, moderate-severe symptoms, medication, age and gender. Hypotheses have been 
suggested in the literature regarding each of these variables; however in the absence of a 
controlled study to address these, firm conclusions cannot be made. Small clinic-based 
samples of children with separate IBD‘s make age-specific analysis difficult (Sonnenberg, 
2007). Additionally, there is a lack of information provided on effect size and clinical 
significance.  This may be due to the subjective nature of self-report scales and lack of clear 
cut-off points for scales such as the IMPACT questionnaire. With the awareness of 
psychosocial factors in measuring disease-related outcome, clinicians may benefit from 
guidance on how to interpret these measures, or encouragement to set goals for raising 
baseline data i.e. improving HRQoL scores amongst their patients (Lowe et al., 2012).  
A criticism of the quality review framework utilised is that an equal weighting was 
assigned to each critique item in the review process. For example, clarity of title of the paper 
is scored and weighted equally to the appropriateness of data analysis used. Despite this 
framework producing a clear overall picture of important aspects of a research study, a more 
robust weighting system or scoring procedure, which takes into account the more critical 
elements to the quality of a study may be beneficial. There were also articles of interest, with 
missing data, which the author could not access that may have been influential in elucidating 




Adolescence is a crucial time of transition and development (American Psychological 
Association, 2002). Literature shows that future symptoms of depression and poor self-esteem 
can be predicted by body dissatisfaction during early and middle adolescence (Holsen, Kraft 
& Roysamb, 2001). Evidence in the literature examining the impact of IBD on children and 
adolescents highlight a range of risk factors, which may impact on the development of self-
image. Research in healthy populations shows that poor self-image can have a detrimental 
effect on psychological wellbeing; therefore it is recommended that clinical services 
supporting children with IBD routinely check psychosocial factors in addition to physical 
health assessments, to identify all psychosocial issues, including emerging body image 
concerns. Group support, similar to the programme described by Grootenhuis et al. (2009), 
would be beneficial for children to strengthen positive coping strategies and provide an 
opportunity to meet other young people with IBD; this could be offered as a standardised 
programme for children after diagnosis or at least at the point of an identified psychosocial 
concern. It is important that clinicians keep psychosocial factors, such as body image, in mind 
when assessing children with IBD, particularly as feelings towards one‘s body can influence 
adherence to treatment regimens and diets (Vlahou et al., 2008) and may be an indicator of 








This systematic review examined nineteen published quantitative papers with a 
measure of body image in children and adolescents with IBD. The results show that, 
particularly for those with mild or no symptoms, trends in body image are similar to healthy 
peers in that body image declines with increased age during adolescence. However, IBD may 
predispose the young person to risk factors, increasing their vulnerability to poorer body 
image. There is some evidence suggesting that increase in disease severity and some 
treatments may negatively influence body image. In the absence of higher quality studies, 
these conclusions remain cautious. Methodological flaws limit the strength of conclusions 
which can be made from this review. There are a number of potentially confounding variables 
relating to body image, which were not consistently reported and controlled for. Furthermore, 
the current body of evidence is lacking in data that can be compared against control groups. 
Research with a specific focus on body image in IBD is warranted to address the issues and 
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Healthcare professionals working with children with a dual diagnosis of type 
1 diabetes and coeliac disease: An Interpretative Phenomenological Analysis 








Background: The psychosocial issues and challenges for young people with a dual diagnosis 
of type 1 diabetes and coeliac disease and their parents have been explored and uncertainties 
within screening and diagnostic processes are documented.  However, the experiences of 
healthcare professionals (HCPs) working with this group has to date remained unexplored.  
Method: Twelve HCPs (doctors, nurses, dieticians) working in this field from three paediatric 
teams were interviewed about their experiences. Transcripts were analysed using 
Interpretative Phenomenological Analysis.  
Results: Three superordinate themes emerged; ‗Connection and burden‘; ‗Diagnoses 
together, but separate and uneven‘; and ‗Sitting with certain uncertainty and complexity‘. 
These represent participants‘ connection to the experience of patients and adding to their 
burden; a sense of disparity in managing the two conditions; uncertainty and complexity with 
the dual diagnosis, and a repertoire of coping strategies utilised. Positive aspects of the role 
(making a difference, improving health and reducing risk) along with coping strategies are 
likely to buffer the challenges of working with this client group.  
Conclusion: Recommendations include a dual review clinic and further support for staff. 
Additional research on medical and psychosocial aspects of this dual diagnosis is needed to 
develop services to support both patients and HCPs.  
 
Keywords: Healthcare Professionals, Experiences, Coping Strategies, Children, Type 1 






Working with Chronic Health Conditions 
With increasing emphasis on extending wellness and improving health, healthcare is 
becoming more complex with fresh challenges for professionals (Department of Health; DH, 
2008). This seems particularly pertinent to the area of chronic conditions, which are 
acknowledged to be complex and challenging for healthcare professionals (HCPs), (DH 2004; 
Royal College of Physicians, 2004). 
Caring for individuals with chronic health conditions requires a range of skills, which 
fall outside the traditional biomedical model of prevention, diagnosis and treatment (Kane, 
Priester & Totten, 2005). Interventions are often rooted in patient self-management, which 
healthcare providers play a key role in facilitating (Schulman-Green et al., 2012), however 
this role can be complex (Thorne & Paterson, 2001). A study of GPs found this complexity 
was linked to their sense of responsibility for delivering high quality care and needing to feel 
in control to meet professional responsibilities (Blakeman, MacDonald, Bower, Gately & 
Chew-Graham, 2005). 
Exposure to ongoing difficulties experienced by patients with chronic conditions may 
increase anxiety, feelings of professional inadequacy and emotional burden amongst 
clinicians (Turner & Kelly, 2000). Burnout, a syndrome of emotional exhaustion (Maslach & 
Jackson, 1981), has been linked to healthcare professions. Ekstedt and Fagerberg (2003) 
highlight the association between burnout and ongoing involvement in emotionally 
demanding situations. Figley (2002) asserts that the additional energy required to provide 
compassion and empathy to individuals with chronic illnesses can have a cost, emphasising 
the importance of self-care. Furthermore, to avoid burnout, Kane et al. (2005) posit the need  
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to draw satisfaction from supporting patients in managing long-term conditions as opposed to 
being able to cure them. 
The Effort-Reward Imbalance (ERI) model (Siegrist, 1996) postulates that imbalance 
in the reciprocity between efforts and rewards at work can lead to stress. This model has been 
applied to the study of nurses, showing an association between high extrinsic effort, low 
extrinsic rewards and emotional exhaustion and depersonalisation (Bakker, Killmer, Siegrist 
& Schaufeli, 2000). Given the importance of the therapeutic relationship in managing chronic 
illness and the patient‘s role in self-management, interactions may not be rewarding if the 
professional does not feel their investment in the patient relationships leads to good outcomes, 
or if there is slow or no improvement in health.  
A further challenge of working with chronic conditions is their nature of uncertainty. 
Han, Klein and Arora (2011) assert that inability to abolish uncertainty in healthcare creates 
difficult challenges for clinicians and patients. Mishel‘s model of illness uncertainty (1988) 
proposes that the psychological effects of uncertainty may provoke feelings of vulnerability 
and avoidance of decision making in HCPs. The importance of maintaining a sense of control 
for physicians is documented (Kearney, Weininger, Vachon, Harrison & Mount, 2009). This 
theme is supported by Shapiro, Shapiro, Robitshek and Shapiro (2011), who discuss how 
treating individuals with multiple, coexisting health conditions has been associated with 
feelings of loss of control.  
Working with Children with Chronic Conditions 
Children and adolescents‘ experience of chronic conditions has been associated with 
poorer emotional wellbeing, psychological distress (Yeo & Sawyer, 2005), longer hospital 
admissions, loss of school days, restrictions to activities (Newacheck & Halfon, 1998), and 
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may have implications for family functioning (Sawyer & Aroni, 2005). Therefore, HCPs 
working with children are not only responsible for providing medical care, but also have a 
role in being alert to psychological wellbeing and social circumstances.  
Studies discussing the experiences of HCPs caring for children with chronic illness 
(including a range of disciplines i.e. nurses, medical specialists, physicians) highlight 
concerns about: sharing illness information (Lochrie, Wysocki, Burnett, Buckloh & Antal, 
2009); the child and family‘s coping abilities (Hoey et al., 2006) and capacity for illness self-
management (Lake & Staiger, 2010). In addition, providing care within the complex 
relationships which can emerge between families and multiple services may create further 
challenges (Dickinson, Smythe & Spence, 2006). Two chronic conditions that may be 
experienced during childhood are type 1 diabetes (T1D) and coeliac disease (CD). 
Diabetes 
T1D is a lifelong condition where the body does not produce the hormone insulin to 
regulate blood glucose levels. An estimated 22,947 children under 18 years in the UK have 
diabetes (this gives a prevalence of 209 per 100,000), 97% of whom have type 1 (Royal 
College of Paediatrics and Child Health, 2009). The UK is the fifth highest country in the 
world for rates of childhood T1D (Diamond Project Group, 2006), with prevalence rates 
rising rapidly (Hsia et al., 2008). 
Diagnosis is based on prolonged elevated blood glucose concentration. Symptoms at 
diagnosis include excessive thirst, urination, and can escalate to diabetes ketoacidosis (DKA), 
a life threatening form of dehydration (Pilek & Starkman, 2014). There is no cure for T1D; 
treatment involves lifelong management of blood glucose levels through diet, blood glucose 
monitoring, insulin replacement and exercise. This is crucial to avoid acute complications 
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arising from low blood glucose levels (hypoglycaemia) and longer term complications 
associated with high blood glucose (hyperglycaemia). Consequences of hypoglycaemia range 
from trembling, blurred vision and difficulties concentrating, to loss of consciousness, seizure 
and possible death (Clarke, Jones, Rewers, Dunger & Klingensmith, 2009). Hyperglycaemia 
is linked to risk of renal failure, eye damage (retinopathy), nerve damage (neuropathy), and 
cardiovascular disease (Daneman, 2006). 
Coeliac Disease  
CD is a lifelong autoimmune condition where the body reacts adversely to a protein 
called gluten, found in wheat, barley and rye. CD is recognised as a multi-systemic disorder, 
with the intestine as the primary disease site (Green, 2005). The body‘s immune system 
responds to gluten, causing inflammation and damage to tissue of the small intestine, termed 
villous atrophy (Alaedini & Green, 2005). CD can present with a varied and wide range of 
symptoms including: chronic gastrointestinal symptoms, abdominal pain, weight loss, 
metabolic bone disease, anaemia, delayed puberty and nonspecific arthritis (Green & Jabri, 
2003; Mearin, 2007). The clinical range can span from asymptomatic (villous atrophy in the 
absence of the classic symptoms; Alaedini & Green, 2005) to severely symptomatic. 
Heterogeneity in presentation of CD can lead to poor detection. A host of screening studies 
reveal between 0.5-1% of populations across Europe, South America, Australasia and the 
USA may have undiagnosed CD (van Heel & West, 2006). Prevalence rates of 1% are 
reported in UK children (Bingley et al., 2004). 
Diagnosis is by blood test and intestinal biopsy. If results are positive, lifelong 
adherence to a gluten free diet (GFD) is the only form of management (Kaukinen, Lindfors & 
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Mäki, 2014). A review by Goddard and Gillett (2006) concludes that left untreated, CD is 
associated with risk of reproductive complications, osteoporosis and small bowel lymphoma.  
Dual Diagnosis 
The prevalence of CD in children with T1D is reported at between 5-7 times higher 
than the general population (Sud et al., 2010). Children with a dual diagnosis of T1D and CD 
(hereafter referred to as dual diagnosis) usually present with asymptomatic or ‗silent‘ CD 
(Telega, Bennet & Werlin, 2008). Therefore, CD is likely to go undiagnosed unless they go 
through screening (Saukkonen, Vaisanen, Akerblom & Savilahti, 2002). The European 
Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) advise that 
children with an increased risk for CD should be screened (Husby et al., 2012). Even if 
asymptomatic, those testing positive are recommended to follow a GFD. The daily reality for 
children with a dual diagnosis include: making food choices based on only gluten free 
options; following a healthy diet with particular control over sugar intake; carbohydrate 
counting at each meal in order to calculate insulin dosage; monitoring insulin pumps or self-
injecting insulin; and regular blood glucose monitoring.   
Psychosocial issues, including depression, anxiety, social withdrawal and lower 
quality of life, have been reported for young people with T1D (Dantzer, Swendsen, Maurice-
Tison & Salamon, 2003; Hanberger, Ludvigsson & Nordfeldt, 2009; Weglage et al., 2000) 
and emotional distress among parents (Bowes, Lowes, Warner & Gregory, 2009; Haugstvedt, 
Wentzel-Larsen, Rokne, Graue, 2011). Adherence difficulties, restrictions of activities and 
negative emotional responses (such as anger and feeling misunderstood) are documented for 
young people with CD (Altobelli, Paduano, Gentile et al., 2013; Roma, Roubani, Kolva et al., 
2010). Adhering to the GFD is in itself associated with psychosocial difficulties (see Howard 
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& Law, 2014). Thus it seems plausible that the experience of managing the dual diagnosis 
would magnify these challenges. Love (2013) explored the challenges for young people with 
a dual diagnosis and their parents in a qualitative study. The nature of chronicity and 
variability with the diagnoses was linked to burden. A theme of protection and loss emerged, 
threatening future hopes and expectations for parents and adolescents, loss associated with the 
adolescents‘ relationship with food and parental protection from future health complications. 
There are ambiguous reports of whether CD and the GFD have implications for blood 
glucose control in T1D (Mohn et al., 2001; Saadah, Zacharin, O‘Callaghan, Oliver & Catto-
Smith, 2004; Schwarzenberg & Brunzell, 2002). The evidence remains unsubstantiated, 
increasing the complexity of managing both conditions. Studies of the long term risks of 
untreated CD in children with T1D are also inconclusive, raising controversy for HCPs 
regarding optimum management (Freemark & Levitsky, 2003; Sud, Marcon, Assor, 
Daneman, & Mahmud, 2011). These authors conclude that unclear evidence about the long-
term risks for asymptomatic CD patients, creates difficulties in developing evidence-based 
approaches. 
The costs and benefits of screening and the additional burden of recommending a GFD 
(particularly to those asymptomatic for CD) has been discussed (Sud et al., 2011). Challenges 
associated with the diagnostic process include the ethics of screening, requirement for sound 
information and support for patients and families (Mimnagh & Thornton, 2006).  
Aims 
Available literature provides evidence of the challenges for HCPs delivering care to 
those with chronic conditions, notably working with uncertainty, a lack of control and the 
need to promote self-management for patients. The challenges facing children and their 
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parents associated with T1D and CD include daily, life-long self-management, which can 
create physical and psychosocial complications that HCPs are required to identify and 
support. Therefore, besides the medical complications presented by this group, psychosocial 
issues add to the complexity for young people, their parents and HCPs (Howard, Law & 
Petty, 2012). Furthermore, the dual diagnosis can bring additional complexity associated with 
screening practices and recommendations. To date, the experiences of HCPs working with 
children and young people with a dual diagnosis remain unexplored. The current study 
explores the experiences of HCPs, working in multi-disciplinary teams with children and 
young people with a dual diagnosis, with the hope of furthering the understanding of this area 






Interpretative Phenomenological Analysis (IPA) is a qualitative approach which 
explores how individuals make sense of their personal and social world (Smith & Osborn, 
2008). This in-depth approach is grounded in the key areas of hermeneutics, phenomenology 
and idiography; with a focus on understanding an individual‘s lived experience through the 
meanings they make. It is particularly suitable for health psychology research (Brocki & 
Wearden, 2006). IPA was chosen for this study since the aim of the research was to gain an 
understanding of what it is like for the HCP‘s to work with this patient group and the 
meanings they assign to their experiences. This focus is fundamental to IPA, in contrast to 
other approaches such as grounded theory, which generates theory from data (Glaser & 
Strauss, 1967) or narrative inquiry, which explores ways that people construct stories to 
interpret the world (Webster & Mertova, 2007).  
IPA recommends data collection methods that facilitate the collection of rich, detailed, 
first-person accounts of experiences (Smith, Larkin & Flowers, 2009). Semi-structured 
interviews lend themselves well to this form of analysis; they offer the participant the 
opportunity to lead the discussion about their experiences. Indicators suggested for high 
quality IPA studies (Smith, 2011, Appendix 1) were consulted to guide and reflect on quality 
throughout the research process.  
Key themes from the literature on working with chronic illness were used to guide the 
development of initial questions, forming a list of open ended questions. A dietician (not 
otherwise involved in this research) from the charity Coeliac UK, with experience of the dual 
diagnosis field, reviewed the interview schedule to assess the relevance and suitability of 
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questions. The final interview schedule is shown in Appendix 2. In concordance with IPA 
principles, this interview schedule was used flexibly, to guide the exploration of experiences 
and meaning-making of participants, whilst following their concerns and ideas elicited during 
the interview.  
Procedure 
The study was granted approval by a University Research Ethics Committee 
(Appendix 3) and the Research and Development departments at recruitment sites. Lead 
clinicians from each service distributed participant information sheets (Appendix 4) to their 
team; this was followed up by the researcher attending a team meeting to allow potential 
participants to ask questions before making a decision about taking part. Participants provided 
written consent (Appendix 5) for data collection and inclusion of verbatim extracts in 
publications.  
Individual, semi-structured interviews (approximately 60 minutes) were conducted in 
the participant‘s place of work. Interviews were digitally recorded and transcribed verbatim. 
There is a risk that discussing difficult work experiences or concerns about patients may 
evoke participant stress or anxiety, and therefore participants were debriefed immediately 
after interviews (Appendix 6) and information from their Trust staff counselling service was 
provided. Following interviews, participants were sent a copy of the transcript for approval. 
They were given a four week period to request changes to be made or to fully withdraw from 






Service Contexts  
Participants were recruited from three services, from separate geographical locations 
across England and Scotland. All have paediatric diabetes teams working in close liaison with 
a gastroenterology team.  All screen T1D patients for CD automatically in the presence of 
symptoms suggestive of the condition. The screening frequency for CD in asymptomatic T1D 
patients varies between the three services (see Table 1).  
Table 1 
Frequency of screening for CD in T1D 




 CD screening 12 months after T1D 
diagnosis. 
 
CD screening every 
second year. 
Service B CD screening recommended after T1D 
diagnosis, patient/parents decides 
whether to be screened. 
 
CD screening every 
second year. 






Children and young people with a dual diagnosis are managed by the diabetes team for 
both conditions in all sites, with additional input provided by the gastroenterologist if there 
are further gastro-related complications. All three services offer quarterly appointments and 
an annual review. The annual review in services A and B are held with the diabetes team. 
Service C offers a dual annual review clinic, where the patient is seen by members of the 
diabetes team and a Consultant Gastroenterologist.  
                                                          




Inclusion criteria stipulated that participants were HCPs (of all healthcare disciplines) 
working in multidisciplinary teams in the National Health Service (NHS) working with 
children with a dual diagnosis of T1D and CD. Participants were required to have worked in 
this area for a minimum of three months (to allow them sufficient experience of working with 
a dual diagnosis to allow for meaningful reflection in interviews).  
Due to the risk that some findings generated by the research could be attributed to 
influences of the service, participants were recruited from multiple services which the 
University of Birmingham had established links with. A purposive sampling method was 
followed; this approach is used when participants are selected due to having knowledge or 
experience of a particular area.  
Four to ten participants are recommended for IPA in doctoral level research (Smith et 
al., 2009). Ten participants were sought, however, a total of twelve volunteered and were 
included in the final analysis, representing a response rate of 40% (response rate calculation 
based on the total number of staff working in the clinical teams at each site meeting the 
inclusion criteria and the number who actually took part). Twelve may be viewed as a large 
sample for IPA, however in an evaluation of IPA papers, Smith (2011) gives examples of 
good quality IPA studies, which have used samples of twelve and guidance is given on 
appropriate IPA with large samples. He recommends that evidence from at least three or four 
participants supports each theme and the prevalence of a theme is indicated. The sample 
consisted of twelve HCPs (female n=11) from three services; participant demographics are 




Table 2  
Participant Demographics 










 Dietician Diabetes 5 years 40-45  
Charlotte Dietician Diabetes 4 years 25-30  
Mandy Dietician Diabetes 5 years 30-35  
Ann Paediatrician  Diabetes 22 years 50-55  
Sophie Paediatrician  Diabetes 8 years 30-35  
Kate Consultant 
Paediatrician 
Diabetes 13 years 35-40  
Sam Consultant 
Paediatrician  
Diabetes 13 years 40-45  
Ashley Consultant 
Paediatrician  
Diabetes 16 years 40-45  
Clare Specialist Diabetes 
Nurse 
Diabetes 16 years 50-55  
Rachel Specialist Diabetes 
Nurse 
Diabetes 26 years 55-60  
Chris Consultant Paediatric 
Gastroenterologist 
Gastroenterology 19 years 46-50  
Alex Consultant Paediatric 
Gastroenterologist 
Gastroenterology 20 years 40-45  
  
                                                          




IPA data analysis followed the approach detailed by Smith et al. (2009, see Table 3). 
Credibility was boosted by cross-checking coding with two academic supervisors. This 
involved the independent coding of samples from three transcripts by supervisors, which was 
then discussed in supervision, in a process of exploring concordance and disagreement of 
themes and interpretations. Emerging themes were discussed in supervision and an IPA 
analysis group throughout the analysis process. Furthermore, a sample script was cross-
checked for credibility via an IPA analysis group27, where members of the group completed a 
section of coding followed by a group discussion.  
Resulting super-ordinate and subthemes were sent to the lead clinicians from each site 
for their views and as an opportunity for them to give feedback. A sample transcript of data 
coding is shown in Appendix 7, this process was conducted for all transcripts. The right-hand 
column includes initial comments on the data; these include descriptive, linguistic and 
conceptual comments. The left-hand margin details the emergent themes. Appendix 8 
provides an example of data supporting one of the super-ordinate themes. All quotes in the 








                                                          
27
 A group of 10 Trainee Clinical Psychologists, using IPA for their doctoral thesis, facilitated by a member of the 




Summary of IPA Analysis Process 




Reading and re-reading the transcript, listening to the interview, 
making note of powerful recollections and initial striking 
observations.  
 
Step 2:  
Initial noting 
Line by line analysis examining the semantic content and 
language on an exploratory level, noting descriptive, conceptual 
and linguistic comments and why these seem significant. 
 
Step 3:  
Developing 
emergent themes 
Analysing exploratory comments to identify emergent themes. 
Emphasising convergence, divergence, commonality and 
nuance. Reduction in the volume of detail of notes, mapping 
interrelationships, connections and patterns between 
exploratory notes.  
 
Step 4:  
Connections 
between themes. 
Re-evaluation of the importance of themes, mapping how the 
themes fit together and producing a structure which allows the 
most interesting and important aspects of the participants 
account to be identified. 
 
Step 5:  
Moving to the 
next case. 
Analysis process is repeated for the next transcript. This new 
transcript is explored and analysed based on its own 
individuality, while ‗bracketing‘ previous analysis ideas as 
much as possible. 
 
Step 6:  
Looking for 
patterns. 
Assessing the connections between each case, how does a 
theme in one case illuminate a different case? And assessing the 












To engage with participants‘ experiences within data, it is recommended that 
researchers reflect on their own experiences and assumptions, and how these have the 
potential to influence analysis (Larkin & Thompson, 2011). This process of reflexivity was 
supported during regular supervision sessions. 
I do not have a chronic health condition and have no special dietary requirements; 
however, my husband has a diagnosis of type 2 diabetes. I observed and shared the shock, 
difficulties and concerns surrounding his diagnosis and life with diabetes since this point. I 
appreciate the restrictions, frustrations and efforts involved in healthy glycaemic control and 
related aspects of health for individuals with diabetes. Prior to this research, my knowledge of 
CD was limited. Along with the development of my understanding of CD, a strong 
appreciation for the challenges and implications for those with this condition has grown 
during the research process. During interviews and data analysis I acknowledged that given 
my experience, it was easy for me to connect to diabetes-related worries, expressed by 
particpants. I have endeavoured to reflect on these and hold them aside while engaging in the 
participant‘s experiences as best as possible, making use of supervision and a peer IPA group 
to discuss this.   
 I think my experience of working alongside various HCPs in inpatient and outpatient 
physical healthcare has been beneficial to contextualising how professionals respond to work 
challenges, since some of the ideas described in interviews (particularly coping strategies) 
were similar to those I have observed. I had an expectation of how HCPs may respond to 
questions regarding their own experiences at work, possibly subjugating expression of their 





Three superordinate themes emerged from the data. A summary is provided in Table 
4. The results section will consider each theme, with quotations28 for illustration and for 
participants to be heard directly. Attention will be paid to the general ideas found across 
participants, the nuances that were important to individuals and the connections between 
these. Guidance for conducting IPA with larger samples, provided by Smith, Flowers & 
Larkin (2009), recommends group level themes, which are illustrated with examples from 
individuals. Furthermore, the identification of recurrence of themes across participants is 
recommended for larger samples. The numeration or recurrence of themes is indicated in 
Table 4.
                                                          
28 For brevity within quotes, unnecessary text has been replaced with …..  




Table 4  




















Empathy and negative view of the diagnoses All 
Feelings of adding to the burden (some guilt) All 
Acting in the patients‘ best interests 
 
Fran, Kate, Clare, Chris, Ann, Ashley, 
Alex, Mandy, Rachel, Sophie 
Diagnoses are 
together; but 




Diabetes comes first and is often prioritised 
 
Fran, Kate, Chris, Ann, Ashley, 
Charlotte, Mandy, Rachel, Sophie, Alex 
Diagnoses going along in parallel but difficult to join 
up. 
Fran, Kate, Chris, Ann, Charlotte, 
Mandy, Rachel, 







Complexity of the role  Clare, Chris, Kate, Charlotte, Rachel, 
Sophie 
Diagnostic grey areas can feel difficult 
 
Chris, Ann, Ashley, Charlotte, Alex, 
Mandy, Sophie 
Striving for accurate control, sitting with sub-optimal 
control of the conditions  
Fran, Kate, Clare, Chris, Ann, Ashley, 
Charlotte, Mandy, Sam, Rachel, Sophie 
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Super-ordinate Theme 1: Connection and burden 
Participants described their perceptions of the difficulties associated with receiving these 
diagnoses, the impact on the young person‘s life, family, future and psychosocial factors. 
They described a connection to what it must feel like and a sense of responsibility for adding 
to the burden. A process of meaning making with regards to their role was shown. 
(i) Empathy and negative view of the diagnoses 
The nature of having this dual diagnosis was frequently described negatively and as 
burdensome; a sense of connection to the young person and family was found. 
…it‟s every impact of their life, absolutely everything. So it‟s not just 
insulin and diabetes and food, it‟s just everything. The whole family is 
affected. Clare, Nurse; 29-30 
All participants talked about the challenges of having a dual diagnosis. There was a repetition 
of the notion ―it‘s bad enough having T1D, but to get CD too‖. There were descriptions of the 
unfairness of the conditions, concerns about the impact they may have on the young person‘s 
quality of life and a sense that it is harder for those diagnosed with CD experiencing few or no 
symptoms (asymptomatic).  
It seems very unfair in some respects to have one chronic condition that 
has a real problem long term, to then have to deal with another problem 
that‟s actually a dietary issue… it must be very difficult to do that. Alex, 
Gastroenterologist; 49-58 
… you do wonder what the long term impact is … they have to focus so 
much on their diabetes and their coeliac disease as well, you know 
whether that takes away some of the energy and um thought they have for 
other things as well. Fran, Dietician; 436-442 
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Empathy was demonstrated by participants positioning themselves in the shoes of 
the young person or parent, questioning how they would cope with these 
challenges and relief that they do not have to. This depth of perspective taking may 
enhance the emotional connection HCP‘s have towards the patients and their 
experiences.  
I think as a parent how hard that would be… I‟ve always thought 
throughout my whole career, „thank goodness my child doesn‟t have 
diabetes‟. And then that added thought of having to deal with Coeliac 
disease on top is a massive challenge. Chris, Gastroenterologist; 28-30 
However, there is also recognition of the range of responses found in families, with a feeling 
of admiration towards the families that cope well with the challenges.  
We have some families that are spot on you know, very diligent and 
avoid gluten at all costs and do all the things they need to do…… I can‟t 
imagine having to worry about things like that. Rachel, Nurse; 232-234 
(ii) Adding to the burden 
 In general with children with this dual diagnosis, T1D is diagnosed first. Therefore they 
are usually known to the diabetes team before receiving the CD diagnosis. Receiving a second 
lifelong diagnosis evoked compassion in participants. The language used to describe the 
second diagnosis (―the double whammy‖, ―a slap in the face‖, ―extra burden‖) suggests how 
negatively they view this outcome.  
Massive, it‟s a massive challenge. Erm, you know having type 1 diabetes 
in itself is a massive challenge, but then getting the second double 
whammy of the impact of having another lifelong condition compounds 




I feel sorry, we all feel sorry for them, because actually we know them 
because they‟ve got diabetes so we‟ve engaged with them, so you do feel, 
we feel sympathetic, so „oh, it‟s the last thing they need‟, you sit there and 
feel „ahh, what a shame‟, Yeah you do feel that, you do. You feel „ahh, I 
didn‟t want it for them‟. Ashley, Paediatrician; 377-380 
All participants shared the view that the second diagnosis creates additional 
challenges and burden for young people and their families. Ashley‘s excerpt 
(above) is reflective of having developed a relationship with the patient and 
family, connecting with them and reacting to the news of the second diagnosis, i.e. 
―I didn‘t want it for them‖. Sam, illustrated by the quote below, provides an 
oppositional relationship within this theme, stating there is more to do practically 
with CD but that this is no different to managing T1D alone.  
I think it‟s more challenging but I don‟t think it‟s different.…. they‟ve got 
two things to do. They‟ve got to count their carbs and give insulin and 
they‟ve got to make sure those carbs haven‟t got gluten in them. So 
they‟ve got two things haven‟t they, rather than one. Sam, Paediatrician; 
153-158 
Almost half of the participants gave an account that portrays a sense of responsibility, and in 
some cases guilt, of their role in ‗giving‘ patients an extra set of issues to manage.  
… when you throw in… Coeliac disease as well, you‟re, you‟re putting 
another pressure on the child…. you do feel bad kind of… having to lump 
something else on them as well…diabetes was bad enough but then 
having to now have Coeliac disease as well, so you feel bad, feel awful 
for the child. Fran, Dietician; 83-102 
Children with T1D who are asymptomatic for CD are picked up through the CD screening 
process. In these situations, the team diagnose a condition they see as burdensome and advise 
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a GFD. This seems to be one of the challenges of working with this group, since these are 
situations where HCPs are not visibly bringing about improved health for the patient in the 
short-term (despite potentially improving health in the long-term), and perhaps elicit less 
gratitude from families, reflected by Alex below.  
….none of them hate you but don‟t thank you for giving them the 
“problem”[inverted commas action made with hands], er because I think 
some families do see it as that because they find it incredibly difficult. 
Alex, Gastroenterologist; 186-191 
(iii) Acting in their best interests 
The challenges described by participants were mostly followed up with descriptions of 
how they manage these feelings or make meaning from them. Ashley (below) refers to having 
responded differently with increased experience. Perhaps less guilt is experienced and a 
process of rationalising develops over time. 
I used to feel more guilty about telling them about the diagnosis, I don‟t 
think I feel that guilt so much now. I think as you get older you feel you 
have the rationale that it‟s not your fault for it, so I don‟t feel guilty. 
Ashley, Paediatrician; 386-391 
Other nuances of this process of rationalising difficulties in their role include; knowing you 
have done as much as you can; following protocol; and acting in the child‘s best interests. 
Fran (below) describes a view shared by all the participants; their role is to give the child the 
best start and to keep them as healthy as possible.   
…. that‟s what it‟s all about, it‟s about keeping them healthy now and 
trying to keep them healthy as they get older… we‟ve got to make a good 




This idea is further supported by a longer, poignant narrative from Ann: 
This goes back a long, long way but probably the one that stays in my 
mind the longest is someone who is now in her twenties, but sadly 
registered blind. She really struggled with her diabetes as a child and this 
was before we routinely screened for Coeliac disease…. we thought [she] 
was significantly struggling with her diabetes, she was failing to thrive…. 
it took us longer than it ought to have taken us to screen for… Coeliac 
disease. She was clearly positive….it made quite a dramatic difference to 
her glycaemic control… I look back and think, if we had done all of that 
earlier, would she still have the diabetes complications that she has.… so 
I can see the benefits of our screening programme. If I need to question 
why we do it, I do always remember that girl and I suppose her missed 
diagnosis. Ann, Paediatrician; 171-173 
Participants describe an important element of their role is to reduce risk; drawing this 
meaning from their role is perhaps a coping strategy, supporting them in bringing about a 
burdensome diagnosis and self-management regimes. The starkness of risk is highlighted in 
Alex‘s quote (below). 
…if you didn‟t pick these patients up, if you didn‟t screen them, what 
actually are the risks to the patient of gut cancer, other autoimmune 
conditions and bone issues or infertility… I actually don‟t honestly know 
that we truly really know what the proper risks are……. but it‟s not 
zero, and as I say, you get a gut lymphoma in Coeliac disease and it‟s a 
death, the 5 years survivals are think are about 10%, so it‟s not good. 
Alex, Gastroenterologist; 209-221 
Testing for CD may also bring some security, since the long term risks are uncertain and ―not 
zero‖. This element of illness prevention was reinforced by eight of the participants. Seeing 




 …once they‟re established on the diet they generally, their symptoms can 
improve and that‟s quite nice to see that you‟ve made a difference maybe 
or made them feel better, despite it posing some additional challenges for 
their day-to-day life. Sophie, Paediatrician; 144-148 
In summary, this superordinate theme features a strong connection from the participants to the 
experience of the young person and their family. The empathy and connection perhaps 
heightens the challenges involved in making a diagnosis and supporting the management of 
the conditions. The feeling of responsibility for their role in this process seems to be managed 
well through a process of meaning making; seeing their role as one to keep the child healthy 




Superordinate Theme 2: Diagnoses are together; but separate and uneven 
The co-occurring nature of the two conditions seemed to automatically lead participants to 
thoughts of comparison, considering which condition is the worst to have or work with. There 
appear to be challenges in joining up the two conditions, working with them together and 
equally. 
(i) Diabetes comes first and is often prioritised 
Narratives comparing the conditions were provided by seven participants. The dominant 
view described T1D as more severe and risky in the short and long-term. Ashley portrays an 
interesting analogy of quantifying the burden.  
… if you look at the weighted burden of managing a gluten free diet 
versus the weighted burden of managing diabetes, the diabetes burden is 
far greater. I think if they were to be able to quantify those on a set of 
scales, the burden of diabetes is greater. Ashley, Paediatrician; 44-49 
Participants spoke respectfully about the challenges experienced with CD, however there was 
an inclination towards describing T1D as the ―worse‖ condition to have. This was linked to 
the possibility of reversing the symptoms of CD as long as the GFD is followed, and their 
view of the complications associated with both conditions. An opposing stance is depicted by 
Charlotte and Clare; they describe how CD can be more arduous on a daily basis for families. 
….quite often, parents will say to me “diabetes was bad enough, but out 
of the two I‟d rather have the Diabetes than the Coeliac to be honest” 
because they feel that it impacts on so much more of their life… they find 
that more of a struggle. Clare, Nurse; 47-56 
 
Perhaps the HCP‘s role is an influencing factor on this perception, with dieticians and nurses 
perhaps seeing different challenges based on the type of contact they have with families. 
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Participants described young people and families prioritising T1D over CD, as shown by 
Chris (below). This interpretation was linked to how families view the risks of T1D as higher, 
perhaps lacking the energy and resources to manage another condition or in some cases a lack 
of CD symptoms. 
….maybe [families] would be erm more inclined to say „well look I'll 
adhere to the diabetic treatment and diet because of the risk of going 
blind or getting kidney disease‟ for example, which is really, really 
serious, „but actually we‟ll just get by with the tiredness‟, and‟ I can‟t 
think about fertility for now because that‟s twenty years away‟ er so it 
might be that you do pick up families that will have that kind of er 
approach. Chris, Gastroenterologist; 193-201 
This trend also emerged within the participants, with six reflecting a sense of priority towards 
the management of T1D or a perception that it is prioritised by others in the team. However, 
contrary to this, Mandy was clear in her message of giving equality to both in order to treat 
the whole rather than the parts: 
I don‟t look at it as one or the other. For me they‟re both equally as 
important, from a dietetic point of view ….we‟re looking at it from the 
whole thing, it‟s not just the diabetes that‟s more important or the Coeliac 
disease we‟re treating the whole thing for the child. Mandy, Dietician; 
258-264 
It is reasonable to assume that diabetes teams would be inclined towards prioritising T1D 
based on it being the team focus, and considering the immediate, serious consequences of 
poorly controlled T1D. However, viewing the two conditions entirely separately perhaps 




(ii) Diagnoses going along in parallel but difficult to join up 
Participants referred to factors that appear to create barriers to working with the conditions 
equally. Chris reflects a sense of responsibility to families to discuss their CD diagnosis, 
however, due to clinic resources, often cannot see them within a preferred time frame: 
…..clinics are so full that they‟re always too full to see children in a 
very timely manner and this is something that I‟m conscious of, that by 
the time I‟m often seeing them too long has gone by and I‟m often erm 
feeling er that er, that we perhaps should‟ve met up sooner… you might 
have already heard the diagnosis from the diabetic team. Chris, 
Gastroenterologist; 138-145 
Use of phrases, such as ―in the back of our mind‖ and being ―conscious of‖ and the tone used 
was indicative of a deliberation, perhaps reflecting that the system is not ideal to fit the way 
Chris would like to support families. There appeared no additional time in appointments for 
dual diagnosis patients, which can create a challenge of covering everything, more so if there 
are difficulties with one of the conditions. With more information to cover, Ann questioned 
how much families may actually take in and remember about CD during initial discussions:  
…we do have our diabetes handbook, which is a big A4 folder with lots 
and lots of pages in it. And there is a section, paragraphs on Coeliac 
disease in there… it would be interesting to know what they have 
remembered other than there‟s a blood test at the next clinic visit. Ann, 
Paediatrician; 267-274 
…..they don‟t get a longer appointment slot in their annual review so it 
can be difficult to cover everything you want in that appointment…you 
very quickly have to prioritise. Charlotte, Dietician; 276-291 
The importance of providing a consistent message to families about how to manage the 
conditions was indicated by half of the participants. The value of consistency from the team 
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was linked to gaining trust and the message it sends to families. Charlotte‘s narrative suggests 
inconsistent messages can make her role difficult; she talks about less consistency with the 
team‘s approach to CD, compared to T1D: 
…always the first thing is getting the diabetes under control and 
everybody agrees and quite often it‟s led from the doctors, they‟ll be like 
„don‟t worry about the gluten free diet‟ but then that‟s a difficult 
situation when later down the line you‟re trying to then re-engage. 
Definitely for the Coeliac disease there isn‟t as much of a team message, 
it tends to be more to the dietician that is constantly as the families 
would say „on at them‟ whereas the doctors kind of leave it to us to deal 
with. Charlotte, Dietician; 522-537 
There is also a feeling of hierarchy here, perhaps that families pay more attention to the 
advice given by the consultant. Service C offers a joint annual review, which was described as 
sending a subtle but positive message to the families about the importance of both conditions. 
…it‟s one thing that‟s joint. And they know we‟re thinking of both 
conditions, it‟s that message to them that we‟re sending, it‟s not just 
your diabetes it‟s your Coeliac disease too that we‟re concerned about. 
Mandy, Dietician; 489-496 
This superordinate theme suggests there are varied views on prioritisation of the conditions. 
Despite participants acknowledging the importance of CD, the dominant stance and tone was 
of T1D being prioritised by young people, families and the team. Some professionals have 
concerns about mixed messages being given to families, which can make their role more 
challenging. Barriers to providing equal care for both conditions include; lack of time in clinic 
and lack of resources. The use of a joint clinic seems to be helpful in demonstrating an equal 
weighting to families.    
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Superordinate Theme 3: Sitting with certain uncertainty and complexity 
Complexities of working with the dual-diagnosis were outlined around uncertainties of the 
diagnosis and management of CD in the diabetes population. The complexity of the dual 
diagnosis can result in less than ideal self-management. 
(i) Complexity of the role 
Five participants raised the issue of working with a condition that is not their area of specialty. 
This theme is illustrated by contributions from a diabetologist and gastroenterologist: 
… being a diabetologist and not a gastroenterologist… sometimes we 
feel uncomfortable about them [diabetes patients with CD] and you‟re 
not quite sure what exactly is the right thing to do. Sophie, 
Paediatrician; 104-108 
… I do tend to hold back and not give as much information as I would 
do with children with just Coeliac disease. So I find that I‟m probably 
not giving as much helpful information in an interaction… you‟re 
avoiding mixed messages and saying the wrong thing. Chris, 
Gastroenterologist; 124-134 
A lack of confidence was expressed by participants about working with the opposing condition 
to their specialist area; feelings of unhelpfulness and uncertainty were described. Charlotte 
spoke of wearing two hats with dual diagnosis patients: 
… it‟s remembering that through the consultation that they‟ll ask you 
what about this? What about that? …. I find that quite difficult erm to 
remember to have both your hats on all the time with these patients and 
kind of remembering all aspects. Charlotte, Dietician; 285 
There was a tone here of needing to know or remember a lot and perhaps being asked 
questions outside her comfort zone. Charlotte commented on the quality of the service offered 
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to dual diagnosis patients; she perhaps feels responsible for offering the same specific 
knowledge and service for CD as the patient would have if managed by the GI team.  Kate 
provides a different stance on complexity below; she again puts onus on the dietician to have 
the specialist CD skills. 
I think you probably don‟t need specialist er clinical skills to look after 
children with Coeliac disease, they need specialist dietetic skills but 
not doctor skills really. Kate, Paediatrician; 100-102 
Participants described managing complexity by being honest with families about not having 
all of the answers and going to the ‗expert‘ for advice (gastroenterologist or dietician). Having 
an expert to consult in such situations appears to offer reassurance. 
We are so lucky to have such a good relationship with the 
gastroenterologist, we have a clear understanding that if there is any 
doubt that we have about Coeliac disease or any of our screening 
results, it‟s automatically discussed with them. So we don‟t ever worry 
about how we‟re going to deal with this or manage this. Ann, 
Paediatrician; 145-149 
The nature of responding to two conditions when you are a specialist in one appeared to add 
an element of complexity for some participants. There were extremes to this idea represented: 
for some it can result in them feeling out of their comfort zone, less helpful or feeling that they 
are providing a lesser service. Others did not think that specialist skills were required or 
acknowledged that specialist skills were held by different professionals, with whom they could 
consult. Experience of working with both conditions, and the relationship they have with the 




(ii) Diagnostic grey areas 
There are uncertainties in the diagnosis, evidence base and management for the dual 
diagnosis and asymptomatic patients, described by half of participants. Chris talks about 
uncertainty for families. 
…there always is er an element of uncertainty, because a positive 
blood test doesn‟t equate to actually having the full blown picture of 
Coeliac disease. So er, they will sometimes go away with a degree of 
uncertainty and that causes anxiety…the families are left with some 
anxiety related to uncertainty. Chris, Gastroenterologist; 69-81 
In circumstances where a diagnosis of CD is unclear, it seems that this brings trickiness for 
HCPs. Uncertainty in diagnosis tends to create anxiety in families; I wonder if this is 
paralleled in some of the HCPs too. 
Asymptomatic patients and those testing positive on the blood test (tTG29) but negative on the 
endoscopy (frequently referred to as ‗grey cases‘) seem the most challenging. Participants 
spoke about their uncertainty of not knowing what is the ―right thing to do‖ with the grey 
cases. As shown in Alex‘s excerpt (below), it seems that clear-cut cases where HCPs can 
intervene and make a difference is rewarding. Circumstances where they are unable to give a 
definitive answer or to see that they are making a positive difference may make cases more 
challenging. 
…on the one hand it‟s a very rewarding condition because it‟s a 
simple change of diet, albeit a big change for families, but you‟ve 
made them better and you‟ve reduced all those risks and they feel 
better. I think the more difficult ones are the patients that are 
asymptomatic. Alex, Gastroenterologist; 105-113 
                                                          
29
 Tissue transglutaminase (tTG), a test used in the diagnosis for CD and to check ongoing 
maintenance of CD 
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Five participants spoke of uncertainty in the evidence base for asymptomatic patients, with 
reference to the lack of good quality longitudinal research into the effects of not following a 
GFD for asymptomatic patients. The ―best‖ treatment options for asymptomatic patients are 
described by Ashley as an ―unknown‖: 
… what really is the best treatment, and that‟s an unknown….. is there a 
benefit to glycaemic control to go on a gluten free diet? And that is very 
debatable. Because actually there may be evidence that actually, you 
exclude the effect of having another diagnosis because they get 
exhausted by it all don‟t they, can‟t continue to carry all this burden, but 
actually the food you eat is different, more rapidly absorbed, less 
complex GI foods, so actually they may actually have a deterioration in 
glycaemic control following the gluten free diet, so it‟s complex. Ashley, 
Paediatrician; 69-80 
Here, the value of a GFD for asymptomatic patients is questioned, suggesting that it may even 
be detrimental to T1D.  The doubt is emphasised in the tone and language i.e. repetition of 
―actually‖. HCPs are trained to follow evidence-based practice; when this is not clear it 
perhaps makes it difficult to make recommendations. Ann‘s quote (below) is an example that 
once again, empathy is shown by participants in considering ―what would I do?‖ And again, 
they manage this challenging position by being honest with the families about the facts, 
allowing them to make their decision about how they want to manage the condition, and 
turning to the ―experts‖ for guidance.  
…we all have discussions amongst ourselves, what would we do in that 
situation? … you feel if all the people in their specialist fields have a 
degree of uncertainty then perhaps we don‟t know…. So yes, there is 




In the grey cases, there seems to be an element of reassurance in the fact that the team has 
ongoing contact with the young person, and therefore they have the opportunity to detect 
health changes, as Ann describes: 
… there is complete reassurance in that we know that we‟re still seeing 
the families, still seeing the children, we‟re able to monitor them, we‟re 
able to identify if something appears to go less well with the child …it 
doesn‟t cause me sleepless nights. Ann, Paediatrician; 340-342 
There was also an element of acceptance from three of the consultants about the reality of 
medicine not always being certain. It is not ideal, but it is not something they worry about. 
Erm, how‟s it feel about not knowing about what the absolute risks are? 
Well I don‟t think you can ever really know… if there‟s uncertainty then, 
it‟s never ideal for any of us is it, because you want to be as definitive as 
you can for the families. I mean does it worry me? Not really, all you 
can do is appraise people with the facts as you see them and hopefully 
those are accurate facts.  Alex, Gastroenterologist; 225-234 
(iii) Striving for accurate control but accepting sub-optimal 
Participants acknowledged the range of patients they see: Some cope well taking the 
diagnoses and recommendations ―in their stride‖, while others struggle. 
… I‟m thinking of some very well controlled Coeliacs who have 
diabetes. But equally I can see not well controlled. There‟s a big range. 
Sam, Paediatrician; 32-33 
Nearly all participants referred to having families who responded very well and worked with 
the team; these were seen as the rewarding or easier cases. However, poor self-management 
was described as one of the challenges. Frustration when management of the conditions could 
be better was noted by eight participants. This was linked to concerns about health risk, and a 
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sense of putting in a lot of effort but not seeing changes was described as ―disheartening‖ 
(Sophie; 222). 
It‟s hard, it‟s frustrating….. if the parents don‟t take it on board then the 
young person isn‟t going to take it on board…that‟s why I worry, that‟s 
what we‟re here for, to try and reduce you know the risks to future 
health. Rachel, Nurse; 227-142 
Cases where participants feel families could be doing more to support the young person, and 
possibly to support them as HCPs were a source of frustration. The pivotal role of families in 
promoting effective management was highlighted by eight participants. A strong sense of 
empathy was shown for the challenges to families, however frustrations seemed to peak in 
cases where they cannot see why a family is unable to follow recommendations or ―do the 
right thing‖, as shown in Charlotte‘s quote below. This perhaps reflects the complexity of 
psychosocial issues impeding adherence, which may be difficult to identify. 
… it‟s very difficult…. we‟ve got the child‟s best interests at heart and 
you are trying to support the families…there are plenty of other families 
that are in the same situation and they are managing to manage their 
diabetes and their gluten free diets.  Charlotte, Dietician; 151-155. 
There was a stance from participants of needing to accept when management of the conditions 
is not ideal. This was in acknowledgement of T1D and CD being difficult conditions to 
manage day-in and day-out.  
…if you can just keep people on board so even if they‟re not doing it 
perfectly but doing it pretty well, then actually that‟s great. So it‟s 
actually about facilitating that suboptimal adherence, saying you know 
actually it‟s not perfect but you know. Ashley, Paediatrician; 322-326 
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The idea of sub-optimal control being ‗good enough‘ in some situations may be challenging to 
HCPs, who train from a medical model to alleviate symptoms and disease. Kate suggested that 
she looks for improvements or outcomes beyond adherence e.g. progress with communication: 
… you do come out and think „well that was quite good‟ even though 
their HbA1C may be crashingly high and you know they‟ve got Coeliac 
disease and they‟re not adhering to the diet…..once you start to have 
better discussions, you might actually be able to….work out what 
might be a way forward. Kate, Paediatrician; 264-269 
It seems that finding a balance between improving control of the diagnoses and engagement is 
a key aspect of the HCPs role, to improve outcomes from a clinical perspective, while having 
insight into the capacity of the young person and family, not ―pushing them‖ to the point of 
losing them. This sense of ―not losing‖ families was noted in five interviews, maintaining a 
positive relationship with families to keep them coming back to clinic, shown in the quotes 
below. 
… just trying to keep that relationship going without them feeling that 
they are being judged um without them feeling that they have to be 
doing it right or else everyone will be feeling annoyed… it‟s not 
perfect but you don't want to lose them, you want them to keep coming 
to clinic. Fran, Dietician; 410-416 
…as long as it‟s not significantly raised you sometimes have to 
compromise… then they‟re happy to keep on with the diet. Otherwise 
you feel you‟re going to lose them completely. Charlotte, Dietician; 
340-342 
There was also a theme running through the interviews of there being a limit to how much 
HCPs are able to do; after that it is the young people and families who choose whether or not 
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they follow advice. This seemed to be another coping response to managing challenges of the 
role.  
In summary, within this superordinate theme, participants revealed the complexity that can 
exist within their role; however they cope with this via processes of knowing their limits, 
being honest with families and seeking support. The rewards from clear-cut cases seem to 
buffer the negative experiences of the grey cases. Another source of frustration can be poor 
self-management, particularly when participants do not understand the reasons for this. 
Despite an imbalance at times between feeling they are putting a lot of effort in and making 








Research has begun to recognise the experiences of young people and their families 
with a dual diagnosis of T1D and CD (Love, 2013), and the practical challenges related to 
screening, diagnosis and management (Freemark & Levitsky, 2003; Sud et al., 2011). 
However, the phenomenology of HCPs working with this client group has not previously 
been explored.   
Three superordinate themes emerged from this study: ‗Connection and burden‘; 
‗Diagnoses together, but separate and uneven‘; and ‗Sitting with certain uncertainty and 
complexity‘. The participants‘ connection to experiences of the young people with a dual 
diagnosis and their families (particularly their role in making the diagnosis) was important, 
and there was a felt sense of disparity in managing the two conditions. As with other areas of 
healthcare in the modern NHS, participants experienced uncertainty and complexity within 
their roles. The use of adaptive coping strategies and ways of making meaning were evident 
in order to combat difficulties in the presentation of the dual diagnosis and the lack of an 
evidence base. 
Enhanced empathy and connection to patients‘ experiences was revealed in this study, 
which may reflect a process of building therapeutic relationships. Larson and Yao (2005) 
summarised that engaging in clinical empathy leads to a sense of increased professional 
satisfaction. Connection and compassion towards patients is cited as a wellness factor 
associated with the absence of burnout (Eckleberry-Hunt et al., 2009), and is also important to 
young people with chronic illnesses and their families (Taylor, Gibson & Franck, 2008). 
Therefore, the findings of empathy and connection in this study are likely to be a positive 
influence on HCP wellbeing, the therapeutic relationship and patient care.  
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HCPs experience a range of presentations working with the dual diagnosis, from 
―clear-cut cases‖ (symptomatic for CD with positive biopsy results) to ―grey cases‖ 
(asymptomatic or those whose CD diagnosis is not certain following biopsy). Uncertainty in 
the grey cases is just described in relation to CD, since T1D is described as being clear. In 
―clear-cut cases‖, facilitating a diagnosis and health improvement was reported as highly 
rewarding for participants.  However, in the ―grey cases‖, the sense of adding to the patient‘s 
burden by screening and possibly finding an additional life-long diagnosis was less 
rewarding. This led to unease in most participants and feelings of guilt in some participants. 
This supports findings by Wallace and Lemaire (2007), who summarised that patient 
interactions for clinicians are a source of both satisfaction and emotional stress; and that the 
feeling of making a difference is important for physician wellbeing and can buffer stressful 
encounters. So within the range of dual diagnosis cases, circumstances where HCPs feel able 
to make a positive difference are likely to buffer the effects of the more challenging ―grey 
cases‖.  
Despite the uncomfortable aspect of ―adding to the burden‖, it is important to 
emphasise the strength of the sub-theme ‗acting in the child‘s best interests‘. Almost all 
accounts of challenges were followed up with narratives that reflect meaning-making, coping, 
and appraising of roles and position in healthcare. These included: Promoting health; reducing 
health risks; following guidelines; and knowing they have done as much as they can. This 
process of cognitive reappraisal might serve as a protective function and has been cited as a 
coping strategy in nurses (Lambert et al., 2007). Within the Process Model of Emotion 
Regulation (PMER), Gross (2002) asserts that emotional impact is altered by changing how a 
situation is interpreted; reappraisal can decrease the experience of negative emotions and 
increase positive experience. Some participants indicated that increased experience in the 
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field had been beneficial in creating positive re-appraisals from difficult situations, leading 
them to experience less guilt. Lambert et al. (2007) also found that distancing and problem-
solving were coping strategies used more often by staff with more experience in the field. In 
this study, the HCPs‘ use of coping strategies to manage difficult experiences perhaps reflects 
professional hardiness and may serve to decrease the risk of burnout and emotional 
exhaustion, found within the healthcare professions (e.g. Erkstedt & Fagerberg, 2003; 
Maslach & Jackson, 1981).  
Within the theme ‗diagnoses together but separate and uneven‘, both narratives and 
interpretations gave a sense of disconnection within the dual diagnosis, with a predominant 
view of T1D being prioritised. This finding is not surprising since it is the diabetes team that 
also manages the CD in this study‘s sample. Interestingly, this theme was also found in a 
study of young people (and parents) with the dual diagnosis (Love, 2013), where T1D was 
viewed as more threatening; this study also reported that there was more of a focus on T1D by 
services and clinicians. It is possible that underlying messages of prioritising T1D could have 
clinical implications for present and future CD management and related physical and 
psychological well-being, such as not following the GFD or seeking support for self-
management difficulties. This highlights the potential for service development, to perhaps 
move towards a more holistic approach, supporting HCPs and patients in managing the 
conditions together and equally. 
The HCPs‘ understanding of how individuals with a dual diagnosis of T1D and CD 
understand and view these multiple conditions seems reflective of a wider issues of working 
with multi-morbidities, including the illness representations held by the individual. McSharry, 
Bishop, Moss-Morris and Kendrick (2013) reported differences in how patients viewed multi-
morbidity of diabetes and depression. Some patients viewed the conditions as related, whereas 
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others perceived them entirely separately. The differences in illness representations was 
linked to; self-management behaviours; conflicts in managing the conditions; and 
prioritization of one condition. McSharry et al. (2013) suggest that HCP understanding of 
how patients perceive multi-morbidity, illness representations and the relationship between 
the two conditions, is likely to be important to understand within patient - physician 
interactions and to inform optimal patient self-management.  
Service development may address the barriers to managing both conditions equally, 
which were cited in this study, including time in consultations, resources and inconsistent 
messages between professionals. Despite participants indicating good multidisciplinary 
relationships and support, inconsistent messages between professionals in the team may 
increase challenges for some clinicians, particularly those who see their role as having more 
responsibility for managing one or other condition (i.e. dieticians and gastroenterologists 
focusing on CD). Moving towards holistic management may include additional time in 
consultation, additional resources, and a dual review clinic (such as that run by Service C). 
Increasing complexity is recognised as central to modern healthcare (DH, 2008). 
Participants predominantly acknowledged the uncertainty within their role; however coping 
responses were varied. For some, thinking they have a lack of expertise in one of the 
conditions seems to have led to feelings of unhelpfulness, uncertainty and lack of confidence, 
which was found in both diabetes and CD specialists. It seemed that those who did not 
experience this difficulty were those who felt buffered by a feeling of security brought about 
by rationalising that it is not their role to be an expert in both; those who accepted that 
complexity and uncertainty are realities of modern day medicine; and those who elicited 
support from colleagues perceived as ‗experts‘. Seeking support is a coping mechanism linked 
to clinician wellness (Lim, Bogossian & Ahern, 2010; Mark & Smith, 2012). These findings 
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suggest that the position of not being an expert may contribute to feelings of stress and 
professional inadequacy for some HCPs.  
A further source of complexity is working with families to facilitate optimal health 
management, and the frustrations when this is not ideal. Participants reflected how they strive 
for the best control for their patients; this is related to reducing risks, which is the 
fundamental goal of their work. Findings revealed that poor self-management for both 
conditions is understood when clear factors such as social issues or lack of resources 
(financial, practical and emotional) can be attributed to sub-optimal management. However, it 
seems frustrating to HCPs when families are deemed to have the resources needed to manage 
both conditions well, but fail to do so. Psychological assessment and shared formulations 
might have potential benefits in these situations.  
Lack of control at work has been linked to stress and vulnerability factors in HCPs 
(Blackeman et al., 2005; Kearney et al., 2009; Shapiro et al., 2011). This feature of working 
with chronic health conditions may be salient to understanding the nature of working with the 
dual diagnosis. A literature review of parents of children with chronic illnesses (Fisher, 2002) 
described a need for parents to seek control to minimise uncertainty, a process which may be 
paralleled by the HCPs in this study. Siegrist‘s Effort-Reward Imbalance (ERI) model (1996) 
may also be helpful in making sense of the challenges. According to the ERI, high cost/ low 
gain work conditions can lead to emotional arousal. Siegrist further highlights the importance 
of control to cope with such demands. Using the ERI, we could postulate that the HCPs in this 
study may feel dissatisfied when their investments do not give rise to rewarding outcomes 
(i.e. good management of the conditions).  
Again, coping strategies were used in response to these situations. Maintaining contact 
with families to monitor health, detect changes and keep them coming back to clinic were 
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seen as important, along with being honest about areas of uncertainty, and equipping families 
with the facts to make their own decisions. This response to uncertainty is similar to that 
described by Hayward (2006), who proposed that, to manage uncertainty in medicine, it is 
important for doctors to recognise processes underlying their attitudes to uncertainty and 
honesty regarding knowledge limitations (e.g., in the dual diagnosis cases this may relate to 
the uncertainty in the research / evidence base). Further responses involved an acceptance that 
―sub-optimal control‖ is sometimes a reality and a rationale that there is a limit to their 
capacity to bring about change.  
Methodological Considerations 
The use of IPA allowed for the open exploration of the understandings and 
experiences of HCP‘s working with this patient group. Since this area has not previously been 
researched, IPA has generated a number of themes, which can be further explored with other 
research methodology, such as quantitative questionnaires. 
Two of the twelve participants were gastroenterologists, and ten were members of the 
diabetes team (occupying varying roles). The sample may be biased towards the experiences 
of the diabetes team; however this distribution of professional expertise is representative of 
the current care for young people with a dual diagnosis nationally. Three sites were included 
for recruitment to boost generalisability of findings. Despite this being a strength of the 
design, uneven numbers of participants from the sites may have biased results towards the 
service with the greatest representation. There was also a majority of doctors and consultants; 




Despite attempts to guide participants towards discussing their feelings, there was a 
sense that at times, some held back in discussing their own emotions and experiences, and 
described an interest in the experiences of the patients. This is perhaps reflective of how 
HCPs view their role, selflessly supporting patients. It may also reflect a sense of discomfort 
or unfamiliarity with reflective practice. It is possible that further research, with specific 
questions based on the themes from this study or for the researcher to be a known, trusted 
individual to the team, would support the researcher to further explore some of the themes 
raised. It is important to note that the participants description and interest in their patients 
experience, is still linked to the phenomenology of their work and also associated to other 
factors that form their working experience, hence are personally salient to them. The 
participants‘ relationship to the things that matter in their lived world is the very essence of 
IPA. This interest in patient experience links to the HCPs own experiences of guilt, concern 
and complexities in their role and coping strategies they use. However, given that the 
participants made frequent reflections on the experience of their patients, and that this is not 
considered the usual focus of IPA, other qualitative methods could have been explored. One 
such approach which could have been used is template analysis (TA, King, 2012), which is 
very similar to IPA. TA is generally used with larger samples than IPA, and is useful for 
exploring relationships and comparing perspectives in order to find meanings. One of the 
strengths of TA is in exploring underlying thinking, feelings and assumptions, therefore on 
reflection, this approach may have been more appropriate to have used. 
Checking of credibility was sought during analysis. Firstly, participants were asked to 
review transcripts prior to analysis to ensure the transcripts were an accurate reflection of 
their intended meaning, all participants reviewed and agreed to their final transcript. The 
process of cross-checking data analysis with academic supervisors and an IPA analysis group 
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adds to the confidence in the processes of arriving at the final themes.  Lead clinicians from 
each site were sent the table of themes following analysis, and invited to contribute any 
feedback, unfortunately, no feedback was provided. It is acknowledged that participant checks 
would have been a valuable stage in assessing the credibility of the emergent themes and 
would have offered more insight into the trustworthiness of the results. 
Clinical Implications  
Since this study is the first to explore HCPs' experience in this area, findings may be 
of interest to other staff in the field, to help make sense of their own experiences, to highlight 
challenges that may have clinical implications, and to offer managers insight into service 
development issues. 
The benefits of peer support, team meetings and increased experience to establish 
appropriate coping strategies were reported in this study.  Mann, Gordon and MacLeod (2009) 
propose that reflective practice for HCPs can help to make meaning of complex situations and 
facilitate experiential learning. Therefore, peer group reflective practice may boost the HCPs 
support network in managing this group of patients. Since a range of views towards the dual 
diagnosis was evident, it may benefit HCPs to be mindful of their own assumptions (i.e. either 
thinking that the dual diagnosis is awful for the young person/ family or thinking that it is not 
an additional burden), to hold these to one side and be receptive to hearing the young person 
and family‘s experiences and needs.   
Regular continuous professional development events are recommended, to provide 
opportunities for specialists in both T1D and CD to share their expertise. Support in 
formulating difficulties in treatment adherence may also be useful. An increased 
understanding of psychosocial issues (of patients struggling with self-management) could 
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help to reduce frustration for HCPs and to offer appropriate support for the young person and 
family. The benefits of integrating psychology within paediatric multidisciplinary teams 
include encouraging psychological thinking and advocating psychosocial factors (Jacobs, 
Titman, & Edwards, 2012). In this sample, psychological input is not available in all services.  
Joint annual review clinics were described positively by those who use them. This 
system could be trialed by other diabetes teams, to evaluate the effectiveness from both a 
HCP and patient perspective. This may boost HCP confidence in managing the condition 




Qualitative literature on the lived experiences of HCPs is limited and what does exist 
tends to be focused on staff working in trauma and end of life care; a focus on long-term 
conditions is scarce. Further research on caring for children with long-term conditions is 
warranted, to appreciate the challenges, meaning making and coping processes that arise. 
Comparing findings from this study to other areas of paediatrics would indicate if experiences 
of working with the dual diagnosis are different or reflect general findings.  
 With limited research and uncertainty about the dual diagnosis, further research is 
warranted. Increased prevalence of children diagnosed with CD (White et al., 2013) and T1D 
(Patterson et al., 2012), suggests a rise in the dual diagnosis can also be expected. From a 
medical perspective, better understanding of the relationship between glycaemic control and 
GFD, and the long-term consequences of not following a GFD for those with asymptomatic 
CD is needed. From a psychological perspective, a larger scale quantitative study of 
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psychosocial issues for young people, families and HCPs would strengthen the evidence base. 
Recommendations have been made based on the findings from this research, however, a study 
specifically eliciting the views of service providers and service users regarding what an ideal 
dual-diagnosis service would look like would support service development. With growing 
prevalence, expansion of this knowledge will enable services to consider specific needs in this 





This study sought to explore the lived experience of HCPs working in the field of 
paediatrics, supporting young people with a dual diagnosis of T1D and CD. Findings reveal 
challenges in this area, centred around managing two chronic conditions (one of which may 
not be the HCP‘s area of specialty); a sense of unevenness in working with the two conditions 
and uncertainty around screening, diagnosis, management and the evidence base. There were 
also positive aspects of the role, such as being able to make a difference, improve health 
outcomes and reduce risk. Positive aspects of the role may serve to buffer HCPs against the 
more challenging aspects. An array of coping strategies were described which are likely to 
serve a protective function, including positive reappraisal, peer support and meaning-making. 
Recommendations for staff support and service development include dual review clinics, 
additional time in appointments, reflective practice and support for psychosocial formulations. 
Further research is needed to develop the evidence base and understanding of the medical and 






Alaedini, A., & Green, P.H.R. (2005). Narrative review: Celiac disease: Understanding a 
complex autoimmune disorder. Annals of Intern Medicine, 142, 289-298. 
DOI:10.7326/0003-4819-142-4-200502150-00011  
Altobelli, E., Paduano, R., Gentile, T., Caloisi, C., Marziliano, C.,  Necozione, S., & di Orio, F. 
(2013). Health-related quality of life in children and adolescents with celiac disease: 
Survey of a population from central Italy. Health and Quality of Life Outcomes, 11, 
204-213.  DOI:10.1186/1477-7525-11  
Bakker, A.B., Killmer, C.H., Siegrist, J., & Schaufeli, W.B. (2000). Effort-reward imbalance 
and burnout among nurses. Journal of Advanced Nursing, 31, 884-891. 
DOI: 10.1046/j.1365-2648.2000.01361.x 
Bingley, P.J., Norcross, A.J., Lock, R.J., Ness, A.R., & Jones, R.W. (2004). Undiagnosed 
coeliac disease at age seven: population based prospective birth cohort study. British 
Medical Journal, 328, 322-323. DOI: 10.1136/bmj.328.7435.322  
Blakeman, T., Mcdonald, W., Bower, P., Gately, C., & Chew-Graham, C. (2006). A 
qualitative study of GPs‘ attitudes to self-management of chronic disease. British 
Journal of General Practice, 56, 407-417. Accessed from 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839014/ 
Bowes, S., Lowes, L., Warner, J., & Gregory, J.W. (2009). Chronic sorrow in parents of 




Brocki, J.M., & Wearden, A.J. (2006). A critical evaluation of the use of interpretative 
phenomenological analysis (IPA) in health psychology. Psychology and Health, 21, 
87-108. DOI: 10.1080/14768320500230185 
Clarke, W., Jones, T., Rewers, A., Dunger, D., & Klingensmith, G.J. (2009). Assessment and 
management of hypoglycemia in children and adolescents with diabetes. Pediatric 
Diabetes, 10, 134–145. DOI: 10.1111/j.1399-5448.2009.00583.x 
Daneman, D. (2006). Type 1 diabetes. The Lancet, 367, 847-858. DOI:10.1016/S0140-
6736(06)68341-4 
Dantzer, C., Swendsen, J., Maurice-Tison, S., & Salamon, R. (2003). Anxiety and depression 
in juvenile diabetes: A critical review. Clinical Psychology Review, 23, 787–800. 
DOI:10.1016/S0272-7358(03)00069-2 
Department of Health. (2008). High quality care for all: NHS Next Stage Review Final 
Report. London: The Stationery Office. 
Dickinson, A.R., Smythe, E., & Spence, D. (2006). Within the web: the family–practitioner 
relationship in the context of chronic childhood illness. Journal of Child Health Care, 
10, 309-325. DOI: 10.1177/1367493506067883 
The DIAMOND Project Group. (2006). Incidence and trends of childhood type 1 diabetes 
worldwide 1990–1999. Diabetic Medicine, 23, 857-866. DOI: 10.1111/j.1464-
5491.2006.01925.x 
Eckleberry-Hunt, J., Lick, D., Boura, J., Hunt, R., Balasubramaniam, M, Mulhem, E., & 
Fisher, C. (2009). An exploratory study of resident burnout and wellness. Academic 
Medicine, 84, 269-277. doi: 10.1097/ACM.0b013e3181938a45. 
116 
 
Ekstedt, M., & Fagerberg, J. (2005). Lived experiences of the time preceding burnout. 
Journal of Advanced Nursing, 49, 59–67. DOI: 10.1111/j.1365-2648.2004.03264.x 
Figley, C.R. (2002). Compassion fatigue: Psychotherapists' chronic lack of self-care. Journal 
of Clinical Psychology, 58, 1433-1441. DOI: 10.1002/jclp.10090 
Fisher, H.R. (2002). The needs of parents with chronically sick children: A literature review. 
Journal of Advanced Nursing, 36, 600-607. DOI:10.1046/j.1365-2648.2001.02013.x 
Freemark, M., & Levitsky, L.L. (2003). Screening for celiac disease in children with type 1 
diabetes two views of the controversy. Diabetes Care, 26, 1932-1939. DOI: 
10.2337/diacare.26.6.1932  
Glaser, B.G., & Strauss, A. (1967). Discovery of grounded theory: Strategies for qualitative 
research. CA: Sociology Press. 
Goddard, C.J.R, & Gillett, H.R. (2006). Complications of coeliac disease: Are all patients at 
risk? Postgraduate Medical Journal, 82, 705-712. DOI: 10.1136/pgmj.2006.048876 
Green, P.H.R. (2005). The many faces of celiac disease: Clinical presentation of celiac 
disease in the adult population. Gastroenterology, 128, 74-78. 
DOI:10.1053/j.gastro.2005.02.016 
Green, P.H.R., & Jabri, B. (2003). Coeliac disease. The Lancet, 362, 383-391. 
DOI:10.1016/S0140-6736(03)14027-5.  
Grey, M., Whittemore, R., & Tamborlane, W. (2002). Depression in type 1 diabetes in 
children: Natural history and correlates. Journal of Psychosomatic Research, 53, 907–




Gross, J.J. (2002). Emotion regulation: Affective, cognitive, and social consequences. 
Psychophysiology, 39, 281–291. DOI: 10.1017.S0048577201393198 
Han, P.K.J., Klein, W.M.P., & Arora, N.K. (2011). Varieties of uncertainty in health care: A 
conceptual taxonomy. Medical Decision Making, 31, 828-838. 
DOI:  10.1177/0272989X11393976 
Hanberger, L., Ludvigsson, J., & Nordfeldt, S. (2009). Health-related quality of life in 
intensively treated young patients with type 1 diabetes. Pediatric Diabetes, 10, 374, 
381. DOI: 10.1111/j.1399-5448.2008.00496.x 
Haugstvedt, A., Wentzel-Larsen, T., Rokne, B., & Graue, M. (2011). Perceived family burden 
and emotional distress: Similarities and differences between mothers and fathers of 
children with type 1 diabetes in a population-based study. Pediatric Diabetes, 12, 107-
114. doi: 10.1111/j.1399-5448.2010.00661.x 
Hayward, R. (2006). Balancing certainty and uncertainty in clinical medicine. Developmental 
Medicine & Child Neurology, 48, 74-77. DOI:10.1017/S0012162206000144  
Hoey, H., McGee, H.M., Fitzgerald, M., Mortensen, H.B., Hougaard, P., Lynggaard, H., 
Skovlund, S.E., Aanstoot, H.J., Chiarelli, F., Daneman, D., Danne, T., Dorchy, H., 
Garandeau, P., Greene, S., Holl, R., Kaprio, E., Kocova, M., Martul, P., Matsuura, N., 
Robertson, K., Schoenle, E., Sovik, O., Swift, P., Tsou, R.M., Vanelli, M., Aman, J. & 
Hvidøre study group on childhood diabetes. (2006). Parent and health professional 
perspectives in the management of adolescents with diabetes: Development of 
assessment instruments for international studies. Quality of Life Research, 15, 1033–
1042. DOI 10.1007/s11136-006-0042-8 
118 
 
Howard, R., Urquhart-Law, G., & Petty, J. (2012). Coeliac disease: Psychosocial factors in 
adults and children. In C, Lloyd & T.Heller (Eds.). Long-term Conditions: Challenges 
in Health and Social Care. (pp. 108-124). London: SAGE. 
Howard, R., & Urquhart-Law, G. (2014). Psychological well-being of children and young 
people with coeliac disease: management and intervention. In C. Martin & T. Dovey 
(Eds.), Paediatric Gastrointestinal Disorders: A psychosocial perspective (pp. 186-
207). London: Radcliffe Publishing Ltd. 
Hsia, Y., Neubert, A.C., Rani, F., Viner, R.M., Hindmarsh, P.C., & Wong, I.C. (2009). An 
increase in the prevalence of type 1 and 2 diabetes in children and adolescents: Results 
from prescription data from a UK general practice database. British Journal of 
Clinical Pharmacology, 67, 242-249. DOI: 10.1111/j.1365-2125.2008.03347.x. 
Husby, S., Koletzko, S., Korponay-Szabó, I.R., Mearin, M.L., Phillips, A., Shamir, R., 
Troncone, R., Giersiepen, K., Branski, D., Catassi, C., Lelgemen, M., Maki, M.,  
Ribes-Koninckx, C., Ventura, A., & Zimmer, K.P. (2012). European Society for 
Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of 
Coeliac Disease. Journal of Pediatric Gastroenterology and Nutrition, 54, 136–160. 
DOI: 10.1097/MPG.0b013e31821a23d0. 
Jacobs, K., Titman, P., & Edwards, M, (2012). Bridging psychological and physical health 





Kaukinen K, Lindfors K, & Mäki M. (2014). Advances in the treatment of coeliac disease: An 
immunopathogenic perspective. Nature Reviews Gastroenterology and Hepatology, 
11, 36-44. DOI: 10.1038/nrgastro.2013.141. 
Kane, R.L., Priester, R., & Totten, A.M. (2005). Meeting the Challenge of Chronic Illness. 
Baltimore: The John Hopkins University Press. 
Kearney, M.K., Weininger, R.B., Vachon, M.L., Harrison, R.L., & Mount, B.M. (2009). Self-
care of physicians caring for patients at the end of life: "Being connected... a key to 
my survival". Journal of the American Medical Association, 18, 1155-1164. DOI: 
10.1001/jama.2009.352. 
King, N. (2012). Doing Template Analysis. In G. Symon & C. Cassell, Qualitative 
organizational research (pp. 426-451). London: SAGE. 
Lake, A.J., & Staiger, P.K. (2010). Seeking the views of health professionals on translating 
chronic disease self-management models into practice. Patient Education and 
Counseling, 79, 62–68. DOI:10.1016/j.pec.2009.07.036 
Lambert, V.A., Lambert, C.E., Petrini, M., Mei Li, X., & Zhang, Y.J. (2007). Workplace and 
personal factors associated with physical and mental health in hospital nurses in 
China. Nursing and Health Sciences, 9, 120–126. doi: 10.1111/j.1442-
2018.2007.00316.x 
Larkin, M. & Thompson, A. (2011). Interpretative Phenomenological Analysis. In D. Harper 
& A. Thompson (Eds.), Qualitative research methods in mental health and 




Larson, E.B., & Yao, X. (2005). Clinical Empathy as Emotional Labor in the Patient-
Physician Relationship. The Journal of the American Medical Association, 293, 1100-
1106. doi:10.1001/jama.293.9.1100 
Lochrie, A., Wysocki, T., Burnett, J., Buckloh, L.M., & Antal, H. (2009) Youth and parent 
education about diabetes complications: Health professional survey. Pediatric 
Diabetes, 10, 59-66. DOI: 10.1111/j.1399-5448.2008.00438.x. 
Love, M.E. (2013). Living with coeliac disease and type 1 diabetes: The experiences of 
adolescents and their parents. Psy.D thesis, University of Birmingham: UK.  
Lim, J., Bogossian, F., & Ahern. K. (2010). Stress and coping in Australian nurses: A 
systematic review. International Nursing Review, 57, 22-31. DOI: 10.1111/j.1466-
7657.2009.00765.x 
Mark, G., & Smith, A.P. (2012). Occupational stress, job characteristics, coping, and the 
mental health of nurses. British Journal of Health Psychology, 17, 505–521. DOI: 
10.1111/j.2044-8287.2011.02051.x. 
Maslach, C., & Jackson, S. (1981). The measurement of experienced burnout. Journal of 
Organizational Behavior, 2, 99-113.DOI: 10.1002/job.4030020205 
Mearin, M.L. (2007). Celiac disease among children and adolescents. Current Problems in 
Pediatric and Adolescent Health Care, 37, 86-105. DOI:10.1016/j.cppeds.2007.01.001 
Mimnagh, J. & Thornton, H. (2006). Coeliac disease and type 1 diabetes in a paediatric 





Mishel, M.H. (1988). Uncertainty in Illness. Journal of Nursing Scholarship, 20, 225-232. 
DOI: 10.1111/j.1547-5069.1988.tb00082.x 
Mohn, A., Cerruto, M., Iafusco. D., Prisco, F., Tumini, S., Stoppoloni, O., & Chiarelli, F. 
(2001). Celiac disease in children and adolescents with type 1 diabetes: Importance of 
hypoglycemia. Journal of Pediatric Gastroenterology & Nutrition. 32, 37-40. 
Murch, S., Jenkins, J., Auth, M., Bremner, R., Butt, A., France, S., Furman, M., Gillett, P., 
Kiparissi, P., Lawson, M., McLain, B., Morris, M., Sleet, S., & Thorpe, M. (2013). 
Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of 
coeliac disease in children. Archives of Disease in Childhood, 98, 806-811. DOI: 
10.1136/archdischild-2013-303996 
National Institute for Health and Care Excellence. (2004). Type 1 diabetes: diagnosis and 
management of type 1 diabetes in children, young people and adults, CG15. London: 
National Institute for Health and Care Excellence. 
National Institute for Health and Care Excellence. (2009). Coeliac Disease: Recognition and 
assessment of coeliac disease, CG86. London: National Institute for Health and Care 
Excellence. 
Newacheck, P.W., & Halfon, N. (1998). Prevalence and impact of disabling chronic 







Patterson, C.C., Gyurus, E., Rosenbauer, J., Cinek, O., Neu, A., Schober, E., Parslow, R.C., 
Joner, G., Svensson, J., Castell, C., Bingley, P.J., Schoenle, E., Jarosz-Chobot, P., 
Urbonaite, B., Rothe, U., Krzisnik, C., Ionescu-Tirgoviste, C., Weets, I., Kocova, M., 
Stipancic, G., Samardzic, M., de Beaufort, C.E., Green, A., Dahlquist, G.G., & 
Soltesz, G. (2012). Trends in childhood type 1 diabetes incidence in Europe during 
1989–2008: evidence of non-uniformity over time in rates of increase. Diabetologia, 
55, 2142-2147. DOI 10.1007/s00125-012-2571-8. 
Pilek, N.L., & Starkman, H.S. (2014). Functional and psychosocial ramifications of type 1 
diabetes mellitus in pediatric endocrinology. In R.D. Anbar (Eds.), Functional 
Symptoms in Pediatric Disease: A Clinical Guide (pp. 133-143). New York: Springer. 
DOI 10.1007/978-1-4899-8074-8_9  
Roma, E., Roubani, A., Kolia, E., Panayiotou, J., Zellos, A., & Syriopoulou, V.P. (2010). 
Dietary compliance and life style of children with coeliac disease. Journal of Human 
Nutrition and Dietetics, 23, 176-182. DOI:10.1111/j.1365-277X.2009.01036.x 
Royal College of Paediatrics and Child Health Science and Research Department. (2009). 
Growing up with diabetes: Children and young people with diabetes in England. 
London: Royal College of Paediatrics and Child Health. 
Saadah, O.I., Zacharin, M., O‘Callaghan, A., Oliver, M.R., & Catto-Smith, A.G. (2004). 
Effect of gluten-free diet and adherence on growth and diabetic control in diabetics 





Saukkonen, T., Väisänen, S., Åkerblom, H.K., Savilahti, E., & the Childhood Diabetes in 
Finland Study Group. (2002). Coeliac disease in children and adolescents with type 1 
diabetes: A study of growth, glycaemic control, and experiences of families. Acta 
Paediatrica, 91, 297-302. DOI: 10.1111/j.1651-2227.2002.tb01718.x 
Sawyer, S.M., & Aroni, A. (2005). Self-management in adolescents with chronic illness. 
What does it mean and how can it be achieved? International Medical Journal, 183, 
405-409. DOI:10.1111/j.1445-5994.2007.01440.x 
Shapiro, J., Astin, J., Shapiro, S.L., Robitshek, D., & Shapiro, D.H. (2011). Coping with loss 
of control in the practice of medicine. Families Systems and Health, 29, 15-28. DOI: 
10.1037/a0022921  
Siegrist, J. (1996). Adverse health effects of high-effort/low-reward conditions. Journal of 
Occupational Health Psychology, 1, 27-41. DOI:10.1037/1076-8998.1.1.27 
Schwarzenberg, S.J., & Brunzell, C. (2002). Type 1 diabetes and celiac disease: Overview 
and medical nutrition therapy. Diabetes Spectrum, 15,197-201. DOI: 
10.2337/diaspect.15.3.197 
Schulman-Green, D., Jaser, S., Martin, F., Alonzo, A., Grey, M., McCorkle, R., Redeker, N. 
S., Reynolds, N. & Whittemore, R. (2012). Processes of self-management in chronic 
illness. Journal of Nursing Scholarship, 44, 136–144. DOI: 10.1111/j.1547-
5069.2012.01444.x 
Smith, J.A. (2011). Evaluating the contribution of interpretative phenomenological analysis. 
Health Psychology Review, 5, 9-27 DOI: 10.1080/17437199.2010.510659 
Smith, J., Flowers, P., & Larkin, M. (2009). Interpretative Phenomenological Analysis: 
Theory, Method and Research. London: SAGE. 
124 
 
Smith, J.A. & Osborn, M. (2008) Interpretative phenomenological analysis. In J.A. Smith 
(Ed.) Qualitative Psychology: A practical guide to research methods (pp. 53-80). 
London: Sage.  
Sud, S., Marcon, M., Assor, E., Palmert, M.R., Daneman, D., & Mahmud, F.H. (2010). Celiac 
disease and pediatric type 1 diabetes: Diagnostic and treatment dilemmas, 
International Journal of Pediatric Endocrinology. DOI:  10.1155/2010/161285 
Sud, S., Marcon, M., Assor, E., Daneman, D., & Mahmud, F.H. (2011). Quality of life in 
children with diabetes and celiac disease: Minimal impact of the ‗double diagnosis‘. 
Pediatric Diabetes, 13, 163–169. DOI: 10.1111/j.1399-5448.2011.00785.x 
Taylor, R.M., Gibson, F., & Franck, L.S. (2008). The experience of living with a chronic 
illness during adolescence: A critical review of the literature. Journal of Clinical 
Nursing, 17, 3083–3091. DOI: 10.1111/j.1365-2702.2008.02629.x 
Telega, G., Bennet, T.R., & Werlin, S. (2008). Emerging new clinical patterns in the 
presentation of celiac disease. Archives of Pediatric Adolescent Medicine, 162, 164-
168. DOI: 10.1001/archpediatrics.2007.38. 
Thorne, S., & Paterson, B.L. (2001). Health care professional support for self-care 
management in chronic illness: Insights from diabetes research. Patient Education and 
Counseling, 42, 81-90. DOI:org/10.1016/S0738-3991(00)00095-1 
Turner, J., & Kelly, B. (2000). Emotional dimensions of chronic disease. Western Journal of 
Medicine, 172, 124-128. Retrieved from 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1070773/?report=classic  




Wallace, J.E., & Lemaire, J. (2007). On physician well being—you‘ll get by with a little help 
from your friends. Social Science & Medicine, 64, 2565–2577. 
DOI:10.1016/j.socscimed.2007.03.016 
Webster, L., & Mertova, P. (2007). Using narrative inquiry as a research method: an 
introduction to using critical event narrative analysis in research on learning and 
teaching. Oxon: Routledge. 
Weglage, J., Grenzebach, M., Pietsch, M., Eldmann, R.F., Innenbank, R.L., Denecke, J., & 
Koch, H.G. (2000). Behavioural and emotional problems in early-treated adolescents 
with phenylketonuria in comparison with diabetic patients and healthy controls. 
Journal of Inherited Metabolic Disease, 23, 487-496. 
DOI:10.1023/A:1005664231017.  
White, L.E., Merrick, V.M., Bannerman, E., Russell, R.K., Basude, D., Henderson, P., 
Wilson, D.C., & Gillett, P.M. (2013). The rising incidence of celiac disease in 
Scotland. Pediatrics, 132, 924-931. DOI: 10.1542/peds.2013-0932.  













Public Domain Briefing Paper 
 
Body image in young people with Inflammatory Bowel  
Disease: A systematic review 
 
& 
Healthcare professionals working with children with a dual diagnosis of type 1 







This paper presents a summary of a literature review of body image in children and 
young people with Inflammatory Bowel Disease. It also includes a summary of an original 
research study, exploring the experiences of healthcare professionals working with children 




Inflammatory Bowel Disease (IBD) is an umbrella term for long-term conditions of 
the gut including Crohn‘s Disease (CD), Ulcerative Colitis (UC), and Indeterminate Colitis 
(IC). Each cause inflammation in the intestine or digestive tract, and can lead to a range of 
painful, embarrassing and serious symptoms. Treatment may include a special tube-fed diet, 
steroids and even surgery (British Society of Paediatric Gastroenterology Hepatology and 
Nutrition, BSPGHAN, 2008). In some serious cases, a surgical stoma is created (opening in 
the abdomen) to allow waste to pass out of the body. IBD has been linked to a greater risk of 
depression, anxiety, poorer social functioning and self-esteem (Mackner, Crandall & 
Szigethy, 2006; Pinquart, 2012). Problems with body image have been found in adults with 
IBD (Muller, Prosser, Bampton, Mountifield & Andrews, 2010), and young people with IBD 
have described feeling different, embarrassed and having low self-respect linked to their 
bodies (Brydolf & Segesten, 1996). Long-term health conditions in childhood have been 
found to affect body image in children and young people; however, no published reviews of 






  Five electronic databases were searched for articles published since 199830. The search 
focussed on children and adolescents aged 0-19 years with IBD, which included a self-rating 
of their body image. The quality of each article was reviewed and given a quality score.  
Findings 
Nineteen articles were included in the review. Body image was measured within 
quality of life questionnaires, and there were no articles using specific body image measures. 
The findings of body image in young people with IBD who have mild symptoms or are free 
from symptoms was found to follow similar patterns to healthy young people. This includes 
body image being poorer with increased age from childhood to adolescence, and affected by 
delayed growth or being different to the norm for the young person‘s age group. Experiencing 
more severe symptoms was the strongest factor associated with lower body image. Body 
image was found to be lowest at the point of diagnosis; this is thought to be because of the 
severity of symptoms at the time before treatment begins. Treatment can reduce severity of 
the disease, however the side effects of some medications and treatment regimens (i.e. liquid 
diets and steroids) was linked to lower body image. There was no evidence in this study to 
show that the type of IBD (e.g. Crohn‘s Disease, Ulcerative Colitis, Indeterminate Colitis) 
significantly affects body image.  
Conclusion and Recommendations 
This is the first systematic review to look specifically at body image in children and 
adolescents with IBD. The review has brought to light the flaws in the current evidence, 
                                                          
30 In 1998 a new form of treatment was licensed for IBD, which reduced the use of steroids 
and surgery. Therefore only research articles published after this date were included. 
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calling for further studies to improve the understanding of this area, which in turn may help to 
support those with the diagnosis. Research using a specific body image assessment, to 
compare with healthy children and adolescents over time would be beneficial. 
Recommendations include the routine assessment of psychosocial factors including body 






 Research shows there are challenges for healthcare professionals (HCPs) working 
with patients with chronic (long term) health conditions (Royal College of Physicians, 2004; 
Han and Klein, 2011; Kane, Priester & Totten, 2005; Turner & Kelly, 2000). Two chronic 
conditions that can occur in childhood include type 1 diabetes (T1D) and coeliac disease 
(CD); these involve life-long daily self-management. Young people with T1D have an 
increased risk of also being diagnosed with CD (Sud et al., 2010). The experiences of young 
people and their families with a dual diagnosis of T1D and CD has been studied (Love, 2013) 
and the practical challenges related to screening, diagnosis and management are reported 
(Freemark & Levitsky, 2003; Sud, Marcon, Assor, Daneman, & Mahmud, 2011). The aim of 
this study was to explore the experiences of HCPs working with children with a dual 





Twelve HCPs (including doctors, dieticians and nurses) working in three NHS teams 
completed individual interviews. Interpretative Phenomenological Analysis (IPA) is a method 
used to make sense of information in order to understand a person‘s lived experience (Smith, 
Flowers & Larkin, 2009); this approach was used to understand the information from 
interviews. IPA is said to be particularly suitable for research in health psychology (Brocki & 
Wearden, 2006). 
Findings 
Three themes came out of the interviews; „Connection and burden‟; „Diagnoses 
together, but separate and uneven‟; and „Sitting with certain uncertainty and complexity‟.  
Findings show there are both challenges and positive aspects to working with this patient 
group.  
The HCPs showed a strong sense of connection to thinking about what the dual 
diagnosis must be like for the young people and families. There was also a sense of unease, 
and at times guilt about making the second diagnosis and advising additional health 
management. Managing two chronic conditions (one of which may not be the HCPs area of 
specialty) was linked to challenges. This was associated with a lack of expert knowledge in 
one of the conditions, lack of additional time and mixed messages coming from HCPs in the 
team. Young people with the dual diagnosis are managed by the diabetes team for both 
conditions and there was a sense of the T1D being prioritised over the CD. Uncertainty in 
areas of screening, diagnosis, and healthcare guidelines for the dual diagnosis can add to the 
complexity for HCPs. Due to the importance of self-management for both of these conditions, 
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it is at times out of the HCPs control to be able to bring about ideal management, as this relies 
on the young person and families.  
The positive aspects of the role include being able to make a difference for the young 
people and their families, improving health outcomes and reducing health risks. The HCPs 
also use coping strategies to manage difficulties; these include making sense of their role (to 
keep their patients healthy and safe), knowing their limitations and seeking support from 
colleagues. The positive experiences and coping strategies seem to help the HCPs manage the 
more difficult aspects of their role. 
Implications and Recommendations 
It may be helpful for both HCPs and patients if services hold dual review clinics with 
diabetes and coeliac specialists.  Additional time in appointments with dual diagnosis patients 
may also help the HCPs to cover all aspects of care for both conditions equally. Since HCPs 
use support from their colleagues to manage difficulties at work, regular reflective practice 
groups and opportunities to share knowledge and experiences may be beneficial. Since it 
seems more difficult for HCPs when the reasons for young people not following their 
treatment/ self-management are unclear, it is recommended that support is offered to 
understand and make sense of how psychological factors may lead to difficulties in self-
management. Further research could continue to explore the experiences of HCPs in other 
areas of child healthcare, to see if there are differences depending on the patient group. There 
is also a need for increased understanding into both medical and psychological aspects of the 
dual diagnosis, and how services can best meet the needs of HCPs and the young people and 
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APPENDIX 1: GLOSSARY OF MEDICAL TERMS 
Term Definition 
Adalimumab Drug name. See biological therapy. 
Barium meal Procedure of radiographing the intestinal tract. 
Biological therapy Treatment aimed at various stages of the inflammatory process. 
They are genetically engineered medications made from living 
organisms that help to correct the imbalance of the gut immune 
system causing the diseases (Rutgeerts et al., 2009). 
Administered intravenously, subcutaneously or by injection. 
Used in the treatment of IBD. 
BSPGHAN The British Society of Paediatric Gastroenterology Hepatology 
and Nutrition. Professional body promoting standards of care 
for children with gastrointestinal, liver and nutritional diseases. 
Colectomy Surgical removal of the colon. 
Corticosteroids Also known as steroids. See steroids. 
Cushingoid features Fatty deposits on the face causing roundness. Side effect of 
steroid treatment. 
Endoscopy  A procedure to examine the inside of the body, through a 
camera (endoscope) inserted through the mouth or anus. 
Enteral nutrition Delivery of a nutritionally complete feed, containing protein, 
carbohydrate, fat, water, minerals and vitamins, directly into the 
stomach or intestine. 
ESPGHAN  European Society of Paediatric Gastroenterology, Hepatology 
and Nutrition. Professional body. 
Fissure Tear or ulcer (open sore) that develops in the lining of the anal 
canal (end of the bowel). 
Fistula Cavity or small channel that develops between the anal canal 
and the skin near the anus. 
Ileocolonoscopy Image investigation of the Ileum (small part of the bowel). 
Ileostomy The small intestine is diverted through a surgically created 
opening in the abdomen. 
Immunosuppressive 
agents 
Drugs that inhibit or prevent activity of the immune system, 
used in the treatment of IBD. 
Infliximab  Biological drug. See biological therapy. 
Naltrexone Drug name. See Opioid antagonist. 
Nasogastric tubes A tube passed into the stomach via the nose. It is used for short 
or medium-term nutritional support. 
Opioid receptor 
antagonist 
Drugs that prevent the body from responding to opiates and 
endorphins.  
Proctocolectomy Surgical removal of the rectum and all or part of the colon. 
Steroids Anti-inflammatory medicine. 
Steroid hump Fatty deposit in the middle-upper back. Side effect of steroid 
medication. 
Stoma Surgically created opening from the colon or intestine to the 
outside of the abdomen. 
Strictures Restriction or narrowing of the anal canal. 
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APPENDIX 2: SEARCH TERMS 
 
Search Terms: 
1. exp body image/ OR self-concept/ OR self-perception/ OR body 
satisfaction/ OR self-image/ OR physical appearance/ OR body 
satisfaction.mp. OR body dissatisfaction.mp. OR body esteem.mp. OR 
IMPACT-I.mp. OR IMPACT-II.mp. OR IMPACT-III.mp. OR IMPACT 
33.mp. OR IMPACT 35.mp. OR piers harris.mp. OR Minneapolis-
Manchester Quality of Life.mp. 
 
2. Inflammatory bowel disease.mp. OR IBD.mp. OR crohn disease/ OR 
ulcerative colitis/ OR colitis/ OR indeterminate colitis.mp. 
 
 
3. Child* OR adolesc*OR young pe* 
 











APPENDIX 3: INDEX OF MEASURES 
 
Abbreviation Title of measure Brief description 
CBCL Child Behaviour 
Checklist 
Questionnaire for parents that measures 
child‘s competences and behavioural 
problems 
CCSS Cantril‘s Self Striving 
Scale 
10 point global rating of quality of life. A 
higher score denotes a better QOL rating. 
CCSS-c Cognitive Control 
Strategy Scale for 
children 
Disease related coping style instrument 
 
CDI Children‘s Depression 
Inventory 
A brief self-report test that helps assess 
cognitive, affective and behavioural signs of 
depression in children and adolescents 7 to 17 
years old. 
CSI Child Symptom 
Inventory 
Behaviour rating scale that screens for DSM-
IV emotional and behavioural disorders in 
children between 5 and 12 years old. 
Dux-25 Dutch Children‘s 
AZL/TNO Quality of 
Life Questionnaire 
Generic quality-of-life questionnaire 
EuroQOL Quality of life instrument, descriptive data on 




Health related quality of life instrument 





Thermometer like scale, provides dimensions 
that measure three levels of severity; no 
problems or some/ moderate problems or 
extreme problems 
FAD Family Assessment 
Device 
60 item measure that assesses family 
functioning on six dimensions; problem 
solving; roles; affective responsiveness; 
affective involvement; behaviour control. 
HRQL Health Related Quality 
of Life 








IMPACT IBD specific HRQOL measure for 9-17 year 
olds. Encompassing six domains: bowel 
concerns, body image, functional/social 
impairment, emotional impairment, 
tests/treatments, and systemic impairment. 
ITIA I think I Am 
 
5 dimensions of self-esteem measured 
(physical characteristics, skills and talents, 
psychological well-being, relationships with 
parents and relationships with others) for 
children aged 10-16 years. 
IBDQ Inflammatory Bowel 
Disease Questionnaire 
A quality of life (QoL) questionnaire for 
patients with inflammatory bowel diseases 
with four dimensions: bowel, systemic, social, 
and emotional. 
KINDL German KINDL 
Questionnaire 
Quality of Life scale. Likert scale items with 
six dimensions; physical well-being; 
emotional well-being; self-worth; well-being 
in family; well-being regarding friendships; 
well-being at school. 
LCAI Lichtiger Colitis 
Activity Index 
 
Subjective and objective criteria to assess 
eight ulcerative colitis symptoms. 
MMQL Minneapolis-
Manchester Quality of 
Life Instrument 
Originally developed for child cancer 
survivors measuring components of; physical 
functioning; psychological functioning; social 
functioning; cognitive functioning; body 
image and outlook on life. 
NZDep06 New Zealand 
Individual Deprivation 
Index 
Index of socioeconomic deprivation 
PCDAI Paediatric Crohn‘s 
Disease Activity Index 
Measure of symptoms of CD 
PUCAI Paediatric Ulcerative 
Colitis Activity Index 
Measure of symptoms of UC 
PedsQL Pediatric Quality of 
Life Inventory 
Measure of child and parents perspective on 
child HRQOL with scales for; physical, 
emotional, social, school related aspects of 
HRQOL. 
PHSCS Piers Harris Self 
Concept Scale 
Assesses self-concept in individuals ages 7 to 
18. Includes  six subscales: Physical 
Appearance and Attributes; Freedom From 
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Anxiety; Intellectual and School Status; 
Behavioural Adjustment; Happiness and 
Satisfaction; Popularity 
RCMAS Revised Children's 
Manifest Anxiety 
Scale 
Measures the level and nature of anxiety, as 
experienced by children  
 
Sense WearPro2 armband Device which provides information on 
physical activity and energy expenditure 
SPAA Self-Perception Profile 
for Adolescents 
7 subscales; scholastic competence; social 
acceptance; athletic competence; physical 
appearance; close friends; behavioural 
conduct; and general self-esteem. 
SCAS Spence Children‘s 
Anxiety Scale 
44 item measure of severity of anxiety 
symptoms in youths. 
SSQ School Information 
Questionnaire 
Gather information from teachers about 
behaviours and symptoms directly associated 
with Attention Deficit Hyperactivity Disorder 
that may displayed in a classroom setting. 
SODA Situational Obstacles 
to Dietary Adherence 
Evaluates the ability of adolescents to cope 
with situational obstacles to their dietary 
adherence. Originally developed for 
adolescents with diabetes. Two scales; 
confidence scale and behaviour scale. 
STAIC State Trait Anxiety 
Inventory for Children 
Self-report measure of state anxiety and trait 
anxiety 
TACQOL TNO-AZL Children‘s 
Quality of Life 
Questionnaire 
A generic health-related quality of life 
questionnaire 
UC Ulcerative Colitis 
measure 
Measure of symptoms in UC. 
UCL-A Utrecht Coping List 
for Adolescents 
44 items to assess coping behaviour in day to 
day situations. 
YSR Youth Self-Report Family of screening tools for behavioural and 










APPENDIX 4: INSTRUCTIONS FOR AUTHORS 
This paper will be edited for submission to the journal ‗Health Psychology Review‘. 













Healthcare professionals working with children with a dual diagnosis 
of type 1 diabetes and coeliac disease 
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APPENDIX 1: IPA QUALITY CRITERIA 
 
What makes a good IPA paper (Smith, 2011) 
1 The paper should have a clear focus 
2 The paper will have strong data 
3 The paper should be rigorous 
4 Sufficient space must be given to the elaboration of each theme 
5 The analysis should be interpretative not just descriptive 
6 The analysis should be pointing to both convergence and divergence 




APPENDIX 2: INTERVIEW SCHEDULE 
(Version 1, 19.10.12) 
The following interview schedule outlines the general topic areas which will be questioned 




Maybe to start, you could tell me why you chose to work with this particular patient group? 
How you came to work in this field? 
 
How would you describe your role with children with T1D and CD and their families/ within 
the team? 
 
What do you think about children who have a dual diagnosis? 
 Do you feel you are seeing more children diagnosed with both conditions? 
 If so, why do you think that is? 
 Do you feel there are particular challenges for these young people and their families? 
 If so, what do you think these are? 
 Are there challenges to this work?  Why?  Why not? 
 
Could you tell me about a patient with a dual diagnosis you‘ve worked with that has been a 
good/or positive experience for you? 
 What made this experience positive? 
 How did you feel about it at the time?  
 Was this a typical case? 
 What do you find is the most rewarding aspect of your role? 
 
Could you tell me about a patient with a dual diagnosis you‘ve worked with that has been a 
difficult experience for you? 
 What made this experience difficult? 
 How did you feel about it at the time? 
 Was this a typical case? 
 What is the most challenging aspect of your role? 
 
Are you involved in the diagnostic process or sharing information about complications 
(possible future complications?) 
 What is your view of how this process is for the child and their family? 
 How do you feel about long term complications for patients? 
 Can you tell me what that‘s like for you? 
 
Do you find yourself worrying about these patients? 
 What are your main concerns? 
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 Do these concerns lead to you changing your practice, doing anything differently? 
 Has your practice changed over time since working with these patients? 
 
I understand that this area involves some focus on a patient‘s own self-management of both 
conditions. What is this process like for you? 
 Do you have any particular concerns about self-management – does this apply to all of 
your patients or just some?  
 What is the most challenging aspect of this for you as a health professional? Or what 
might be the most challenging aspect of this for a health professional working in this 
area? 




As part of your role, are you involved in dealing with situations where there are strong 
emotions? 
 What sort of emotions have you experienced in the children with a dual diagnosis and 
their parents?  
 How do you feel about that/ what is it like for you? 
 Do you have any particular ways of responding to these situations where patients/ 
families are highly emotional? 
 Are there any support networks in place for you? (supervision, group supervision, 
formal/informal) 
 Do you make use of these? How are they beneficial? 
 If not, what stops you? 
 Is there any form of support which is not currently available which you think would be 
helpful? 
 
End of the interview 
 
We‘ve now covered all of the questions I wanted to ask. Is there anything you‘ve not had the 
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APPENDIX 4: PARTICIPANT INFORMATION SHEET  
 
 
Exploring the experiences of health professionals working with children with a dual 
diagnosis of type 1 diabetes and coeliac disease. 
My name is Victoria Hobday, I am a Trainee Clinical Psychologist at The University of 
Birmingham, completing a Doctorate in Clinical Psychology. I would like to invite you take 
part in a research study. Details of the study are outlined below, which explains the purpose 
of the study and what it would involve for you. Please read this information before you decide 
whether or not you would like to participate. If you have any further questions please feel free 
to contact me. 
 
 What is the purpose of this research? 
There has been a growing research interest in children and young people with a dual 
diagnosis of type 1 diabetes and coeliac disease; current research being undertaken at The 
University of Birmingham is focusing on the experiences of children with this dual diagnosis 
and their families. This study aims to explore the experiences of health professionals working 
with children and young people with a dual diagnosis of type 1 diabetes and coeliac disease, 
to develop individual and shared accounts of the experiences of working in this field. 
 
 
 Why have I been invited to take part?  
Your team has been identified as a multidisciplinary team working with children and 
young people with a dual diagnosis of type 1 diabetes and coeliac disease. Health 
professionals who have worked with this patient group for a minimum of three months are 
invited to take part.   
 
 What will happen to me if I agree to take part? 
If you agree to take part in this study you will be asked to participate in an individual 
interview with me which will be audio-recorded and transcribed verbatim.  The interview 
will last up to an hour and will be arranged at a time and place convenient to you.  If you 
are interested in taking part in this study, please contact me using the details below. You 
will have the opportunity to ask any further questions before arranging the individual 
interview. Prior to the interview you will be asked to sign a consent form for your 
participation. For the purpose of confidentiality, you will be assigned a pseudonym. Your 
consent form will be kept separate from your data and only your interview data will be 
associated with your pseudonym.   
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The interview will ask questions about your experiences of working with children with a 
dual diagnosis of type 1 diabetes and coeliac disease. The interview will then be 
transcribed verbatim; any identifiable information will be omitted for the confidentiality of 
you and your team. 
  
 
 What will happen if I do not want to carry on with the study? 
Your participation is voluntary and you are free to change your mind and withdraw at any 
time during the research interview, without giving a reason. You may withdraw your 
interview entirely or in part, without giving any reason and without judgement up to two 
weeks following the interview. Should you choose to withdraw from the research, you can 
contact me on the details below and your data will be deleted. The date by which you can 
withdraw from the study will be provided to you on the day of your interview.  
 
 Expenses and payments 
Interviews will be arranged at a time convenient to you and will take place at your usual 
place of work. No expenses or payments will be provided to you. 
 
 What will happen to the results of the research study? 
The recordings from the interview will be heard only by me, and the transcripts will be 
looked at by myself and my research supervisors at The University of Birmingham. 
Transcripts may be checked by external examiners as part of the Doctorate qualification 
but no identifiable information will be included in these circumstances. Data will be stored 
securely on a password protected device and your transcript will be associated with your 
pseudonym only.  
Quotes from the interview may be used in the write up of the study for my Doctorate in 
Clinical Psychology, and in any subsequent publications. However any identifiable 
information will be omitted or changed from quotes to ensure you will not be identifiable 
by comments used.  
An executive summary of the research and findings will be made available to you and 
your team. The details of any subsequent publications made as a result of this study will 
also be made available. 
Audio-recordings and interview transcripts will be kept by my academic supervisors at 
The University of Birmingham until the qualification has been awarded (not usually more 






 What happens if I have any further concerns? 
Should you have any questions or concerns at any point during or following the research 
process, you can contact the researcher by telephone or email. 
 
Thank you for reading this information and for considering the research. If you would like to 
discuss any aspect of this research or to indicate your interest in taking part please contact 
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APPENDIX 5: CONSENT FORM        
Research site: ....................................... 
Study number:....................................... 
Participant Identification Number:...............  
Title of Project: Exploring the experiences of health professionals working with 
children with a dual diagnosis of type 1 diabetes and coeliac disease. 
Researcher: Victoria Hobday 
  Please initial box 
1. I confirm that I have understood the information sheet dated 19.10.12 (version 1) 
for the above study. I have had the opportunity to consider the information, ask    
questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at  
any time during the research interview, without giving any reason. 
 
3. I understand that the research interview will be audio-recorded  
 
4. I understand that following the research interview, the researcher will send me  
a copy of my interview transcript. I will be given a period of time for reflection  
and allocated a date, by which I can request changes to the transcript or to  
withdraw my data. The researcher will then contact me at which point I may withdraw 
my interview entirely or in part, without giving any reason. 
 
5. I understand that the data collected during this study will be looked at by  
the researcher and relevant others at the University of Birmingham to ensure that  
the analysis is a fair and reasonable representation of the data.   
 
6. I understand that direct quotes from my interview may be published in any write-  
up of the data, but that my name will not be attributed to any such quotes and  
that neither I nor my team will be identifiable by my comments. 
 
7. I agree to take part in the above study. 
 
 
................................  ...................  ...................................... 
Name of participant  Date   Signature 
 
 
...............................  ...................  ...................................... 
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APPENDIX 6: DEBRIEF SHEET 
 
 
Exploring the experiences of health professionals working with children with a dual 
diagnosis of type 1 diabetes and coeliac disease 
 
Thank you for taking part in this study. 
If you have any worries or concerns after talking about your experiences at work, staff 
support is available within your Trust, the attached leaflet provides information on this service 
and how you can access this support.  
I will be in contact to give you a copy of the transcript from your interview. If you have any 
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How does that feel for you in those situations? 175 
Erm, it s e  diffi ult. E  e ause at the e d of the da  e e got the hild s est i te ests at 176 
heart and you are trying to support the families. But then at the other end of the spectrum, 177 
you know there are plenty of other families that are in the same situation and they are 178 
managing to manage their diabetes and their gluten free diets, so just trying to work with 179 
them as best as possible.  180 
And you said if they tend to be following the diabetes diet quite well they can often manage the 181 
coeliac diet well too. Can you tell me more about that? 182 
Yeah defi itel , I ould sa   e pe ie e ould e that if the e ell o t olled ith thei  183 
dia etes the  te d to e uite ell o t olled ith the oelia  a d it s ore so the kids that 184 
a e t e  ell o t olled ith thei  dia etes that a e t uite as st i t ith thei  glute  f ee 185 
diet as well. 186 
The other thing you said was the difficulties in keeping children and families motivated. Whose 187 
role were you referring to in keeping the child motivated? 188 
I thi k it s e a d the pa e ts, a it of oth eall . I thi k initially a lot of the families are very 189 
motivated and go about reading labels and being super, super strict And then as time goes by 190 
we do an annual review appointment and you kind of go back over the basics and you see that 191 
the  sa  oh the e as that takea a  a d e e t uite su e if it as glute  f ee o  ot  a d 192 
ou a  see that the e s little thi gs that a e sta ti g to slip i , so ou do ha e to gi e the  a 193 
e i de . A d a lot of fa ilies ill e like it s ee  good to eet a d ou k o  it e i ds us 194 
to e a little o e autious agai . A d I guess the sa e app oa h ith thei  dia etes, e 195 
meet them annually and every so ofte … a lot of fa ilies ill e ery strict with the carb 196 
ou ti g i itiall  a d the  so eti es ou ll eet the  a fe  ea s do  the li e a d thi gs 197 
have slipped a little bit and they ha e t app e iated that their child has grown and their 198 
po tio  sizes ha e ha ges a d the e still guessing the same numbers as they did when they 199 
e e s alle . “o it s all a out getti g the eighi g s ales out agai . “o it s a e  si ila  200 
app oa h e ll take to oth o ditio s, ith a little e i de  a d going back to basics and the 201 
importance of being strict with both conditions. 202 
We e  = olle ti e. Ha e 
responsibility for others. 
Tone: Irritable/ frustrated. 
Trying to do the best by 
everyone. Sense of 
frustration? Why can t they 
just do it? Others do! 
Discrepancy between 
feelings of frustration with 
the families & empathy. 
 
Copers vs non-copers. 
Managing is about 
o t ol/st i t  
Joint responsibility. This 
seems different to tone of 
other sections where she 
takes more responsibility. 
Motivation can drop over 
time. Responsible for 
i gi g the  a k  Having 
thanks/ reward for re-
motivating them. This is 
valued. The task of 
managing both over time, 
they can slip. Having to go 
over it again. Sense of ever 
making progress? Control 
going up and down. Need 
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And, erm, you also said that one of the things for parents is to think about counting the carbs 203 
a d their ow  u era y a ility o es i to that. Ca  you tell e what’s that’s like for you to 204 
work with? 205 
E , ell I thi k it s ell known that numeracy levels in the UK are much lower than the rest of 206 
Eu ope, a d e defi itel  e ou te  that ith ou  fa ilies i  that f o  diag osis, e  it s 207 
sometimes very easy to see if families are struggling with numbers. Because diabetes is all 208 
numbers, your dose of insulin is a number and your meter is a number, every food label is a 209 
number. So some families, some parents have been dyslexic with numbers, others have 210 
o iousl  la ked s hool e  ea l  a d did t atte d u h he  the  e e the e, so ha e t 211 
eall  e ou te ed o  u de sta d de i al poi ts efo e. “o it s eall  goi g back to basics. I 212 
thi k as a dieti ia , ou ha e t ee  taught ho  to e a ath s tea he  at u i e sit , ut it s 213 
defi itel  skills that e e all had to take i  ou  approach and I kind of take a bronze, silver and 214 
gold approach to my teaching with families. So you start with very basics you know and erm 215 
ith a  ou ti g a d if the e a agi g that the  ou ki d of p og ess a d p og ess u til 216 
you get to the point whe  the  a e dose adjusti g thei  i suli  a d ou k o  the e got a 217 
e  fle i le a  of eati g. But so e fa ilies do t do that, the  ould e e  ope ith that, 218 
“o ith sta t ith hat the  all o siste t a s  a d e gi e the  a e  set a ou t to stick 219 
to at meal times and we work with them a lot with pictures with that and erm weighing scales 220 
so the  do t ha e to el  o  a tuall  o ki g thi gs out as u h the sel es. “o the  ha e the 221 
benefit on the ward, they have a few days of seeing what the meals look like and a lot of 222 
families erm kind of go on that and try and give their children a very similar looking portion to 223 
hat the  had o  the a d. A d the  e use the a s a d als  ook a lot, e ause the  the  224 
ha e a pi tu e a d u de eath the e got the weight of the actual portion size, so we give 225 
the  f ee eighi g s ales he  the  fi st get diag osed a d a a s a d als  ook. “o at least 226 
then all they need to do is weigh the portion and that can usually manage that. Erm and then 227 
you know that the carbs will be accurate enough. And a lot of families, we encourage them to 228 
bring in labels or foods they would usually eat frequently. 229 
Additional challenge to work 
with. Families overwhelmed 
with numbers, she s asking 
them to do things they find 
hard. 
Maths- not trained for, had to 
take on additional skills. I  a 
dietician not a maths 
teacher! Teacher role, take 
them one step at a time 
(education language used 
o ze, sil e , gold ) 
Flexible, adaptive. 
Interesting- no control 
discourse on this page. 
Adapting style to get it right, 
pitch it right for their abilities. 
Doing it together. 
(She commented about 
benefits of the ward 
previously)The ward is 
beneficial-is there something 
about this feeling safer for 
her? More staff input? Try to 
minimise pressure on the 
families- practical things. A 
sense of reassurance that 
there is some accuracy. 
A u ate e ough -change in 
































 APPENDIX 8: EXAMPLE OF SUPPORTING QUOTES 
Superordinate theme 2: Diabetes comes first, but is separate and uneven 
Diabetes comes first Going along in parallel but difficult to join up 
Erm, I think the complications with coeliac 
disease probably feel less severe to me than 
the complications of diabetes, erm, so er it 
doesn't feel too bad actually. I think always 
comparing the two then diabetes is the one 
that s u h o e of a halle ge e ause it, 
the o pli atio s a e u h o e eal… e  
and with coeliac disease I think you can if you 
manage it well than you can say everything 
going to be ok. Kate; 401-405 
 
My feeling again, without looking at a whole 
clinic, is that some of our teenagers are 
completely ignoring their coeliac disease. 
Some of them are also ignoring their diabetes, 
but not all of them, so some of them will 
prioritise their diabetes over their coeliac 
disease a d so e of the  o t p io itise 
eithe . U , it s u usual i   e pe ie e to 
fi d so eo e ho s p io itisi g thei  Coeliac 
over their type 1 diabetes Chris; 53-57 
 
the e s a huge e otio al upset he  ou get 
a diagnosis of something like type 1 diabetes 
i  pa ti ula . E , I do t ha e eithe  o ditio  
so it s diffi ult fo  e to sa  i  te s of hi h 
one I would personally prefer to have if you 
e e goi g to gi e e the t o… a hoi e, 
the  I d p efe  to ha e oelia  disease 
e ause it s… ou ha ge ou  diet, I  goi g 
to sa  just  ha ge ou  diet, it is a uite 
significant change to your diet, but you 
change your diet and then get on with your 
life. Whereas diabetes is much more invasive 
in terms of your day-to-day living, you have to 
count carbohydrates, do your blood tests, 
Alex; 62-69 
 
I think those complications mainly relate to 
diabetes, because the complications are much 
more significant and er generally are more life 
limiting medically, erm because the chances 
of something life threatening happening with 
coeliac disease is very very slim. Erm even if 
the  do t sti k to the diet, a d that s the 
t uth e ause the e s a  people ith 
I ofte  feel the e s ot uite e ough ti e i  a 
li i  setti g. I  thi ki g pa ti ula l  of the 
individuals with a diagnosis of type 1 diabetes 
and coeliac disease, I probably spend a 
significant portion of the consultation talking 
about the diabetes and then ask any symptoms 
and how are things going with the gluten free 
diet, ou k o  it s ot the fi st thi g e talk 
about when they come in.…the focus is not 
massive by any manner of means on the coeliac 
disease. Ashley; 46-58 
 
within the confines of our diabetic clinic 
appointment, most of the plans were related to 
her diabetes, with leaving the onus on the 
mother to continue with contact with the 
diabetes nurse specialists and to let us know 
how things were going from the gluten free diet 
point of view. Kate; 73-79 
 
ou e got a lot to t  a d dis uss i  that sho t 
li i  appoi t e t. A d ou k o , as I  
reflecting on this now, the coeliac disease was 
not first and foremost, it was mentioned all of 
the a  th ough the o sultatio , ut it as t 
a e eed to fo us o pletel  o  a gluten free 
diet at this poi t . Ann; 84-88 
 
I feel e do e tio  is, ut e e also talki g 
about a lot of other things. I know we have a 
plan to have something in writing to hand to 
them; we do have our diabetes handbook, 
which is a big A4 folder with lots and lots of 
pages in it. And there is a section, paragraphs 
o  oelia  disease i  the e, so if ou e sa i g 
are people i fo ed a d told, e d sa  oh es , 
but if you were to question them a week after 
coming to visit at the new patient clinic, again it 
would be interesting to know what they have 
e e e ed othe  tha  the e s a lood test at 
the next clinic visit. Ann; 267-274 
 
The diabetes is what they struggle with. And 
a e it s  ias as ell e ause I see the 
diabetes. But in the coeliac clinic, because our 
patie ts do t go to the oelia  li i  just o e 
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untreated coeliac disease so the risks for 
example of cancer are not zero but they are 
much smaller than the risks to the hild s 
health from poorly controlled diabetes. 
Sophie; 181-186 
 
I suppose I do t see it as the ost i po ta t 
role in clinic to be persuading someone who 
has had discussions with other people about 
whether they do or do not go on a gluten free 
diet. They tell us their child is asymptomatic 
their child is thriving, their diabetes control 
a  ot e e elle t ut it s ot so ethi g I 
push. Erm, obviously I would take guidance 
from the gastroenterologist and other people 
in the team if they strongly feel we need to 
make a huge effort Ann; 213-220 
 
I think personally I would feel that the coeliac 
takes less and less or a priority for them, 
the e follo i g it a d a e it is easie  fo  
them because of all of the products that are 
a aila le, I do t k o . A d eah it does t 
seem a big issue for these families. I saw a girl 
este da , I had t thought of he  u til o , 
ho s o  a oelia  glute  f ee diet a d ou 
k o  i  the o sultatio  e ust e talked 
about that and she had some abdominal 
issues, e ust e talked a out that fo   o   
minutes in a 30-40 minutes consultation. 
Ashley; 270-276. 
 
I thi k it is ha de  e ause the  do t al a s 
see the symptoms with coeliac disease, erm 
so I think a lot of families will take more risks 
with their coeliac disease and maybe go 
so e he e a d thi k this is p o a l  ot 
full  glute  f ee  o  the e ould e oss-
o ta i atio  ut the  take the isk ith 
oelia  disease athe  tha … e o iousl  
have kids with allergies and things, so if the 
child had a nut alle g  the  just ould t take 
that chance. Erm so I guess they often put a 
lesser significance on the coeliac diagnosis 
than they do erm with their diabetes, I 
definitely think coeliac disease comes down 
the list. Charlotte; 515-522 
 
Yeah, I think I proba l , I do t look at it as 
to the diabetes clinic, we want to do all the 
things that I think we should do in the diabetes 
clinic. Ashley; 171-177 
 
it s a sha e fo  the hild e ause I feel the  
need to be supported really and like I said 
everyone needs to be giving the same advice to 
the  a d the  eed to k o  hat it is the e 
supposed to e doi g, ot e … ot ha i g o e 
person telling them one thing and another 
saying different Fran; 469-472 
 
often the dieticians will take over afterwards 
for the on-going management, and the diabetic 
dietician will primarily lead on that. Er, so it s a 
little it disjoi ted i  that it s ot  gast o-
dietician that provides the er main advice and 
follow up…that s h  e ha e a joi t li i  ith 
the endocrinology team on occasions to try and 
provide coordinated advice with the dietician 
and the gastroenterologist and the 
endocrinologist in the same room. Chris; 15-20 
 
the li i s a e so full that the e al a s too full 
to see children in a very timely manner and this 
is so ethi g that I  o s ious of, that  the 
ti e I  ofte  seei g the  too lo g has gone 
 a d I  ofte  e  feeli g e  that e , that e 
pe haps should e et up soo e  a d so e do 
spend a lot of time telling them, actually you 
a e i po ta t to us a d the fa t that ou e 
waited quite a long time for a gastro 
appointment. And you might have already 
heard the diagnosis from the diabetic team, 
e  a d I hope the e al ight ith that 
e ause e , it s, the e hea d it so eti es 
second hand. But in fact the diabetic team, I 
think, handle it quite sensitively. Chris; 138-145 
 
that s so ethi g that s also i  the a k of ou  
mind is that we like to see children in a really 
ti el  a e  a d ideall  e d see the  as 
soo  as the esults o e a k, ut I do t get 
their results sometimes for four weeks after 
their tests, which is actually too lo g. “o e e 
also dealing with families who, where the 
s ste  does t o k as ell as e thi k it 
should do, so we also have that sort of dynamic 
in our consultation Chris; 147-151 
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o e o  the othe . Fo  e the e oth e uall  
as important, from a dietetic point of view I 
eed to ake su e that the e eati g e ough 
alo ies, the e eati g e ough a s, the e 
diet is ut itio all  ala ed, the e g o ing, 
the e ot ha i g a  s pto s, the e 
taki g thei  i suli , the e H A  is o i g 
do  o  is good, e e looki g at it f o  the 
hole thi g, it s ot just the dia etes that s 
o e i po ta t o  the oelia  disease e e 
treating the whole thing for the child. Mandy; 
258-264 
 
I e got o e gi l that s eall  st uggli g a d 
she sa s it s ot the dia etes it s the oelia  
disease. Whe eas usuall  the ll sa  it s the 
othe  a  ou d. But she sa s I ould deal 
with it if it was just one, I could deal with just 
the dia etes, I a  do the i suli  ut she just 
wants to eat the same foods as her friends. 
It s all a out fitting in with the children Fran; 
347-351 
 
Yes, yes, yes, I think because you know the 
diabetes has been around for a long time and 
you know its been at the forefront and going 
back to the fact that they may not have had 
signs and it is difficult to avoid gluten in stuff. 
All of those reasons make it a second best 
sometimes I think. Rachel; 229-231 
 
ou k o  ou do t a t to thi k of the  as 
having poor health outcomes because their 
health has ee …thei  dia etes has ee  
poorly controlled in younger life but 
unfortunately you do have a lot of patients 
who do have poor control despite our best 
efforts to engage them so I think that can be a 
very challenging erm area. I suppose in terms 
of the coeliac, although its that kind of dual 
burden and dual diagnosis, I think diabetes is 
often er has more of a significant impact on 
their day to day life and risks for long term 
health implications. So I think that would 
probably be the dominant one that would 





“o ou e gi e  the i fo atio  up to a poi t, 
but you can see from their point of view, if she 
a t see that he  daughte  has a  a do i al 
s pto s, she ould t see the li k pote tiall  
between her incomplete gluten free diet and 
her poor diabetes control. Clare; 79-82 
 
I would hope that I always give the opportunity 
for people to i g the  up, ut ofte  ou e 
a a e that ou e a e spe t o e ti e on 
one aspect of diabetes care, Ann; 121-123 
 
if you have team members giving different 
essages to fa ilies, the  do t feel that the  
have someone that they can trust. I think the 
consistency in the message and honestly in the 
message is something that we have an 
obligation to give to the families. Ann; 224-230 
 
Definitely the diabetes is easier to hold, I do 
that all the ti e, ut I do t do the oelia  
disease as u h ….. its kind of just 
e e e i g ot to suggest a thi g that is t 
erm, suitable… it can be hard to remember 
a out the oelia  disease as ell….“o it s a lot 
of detailed i fo atio  ith that, so it s t i g 
to remember then also the coeliac disease in 
there can be a bit difficult. Charlotte; 360-378 
And even in terms of how the team approach it, 
erm if you have a very poorly controlled erm 
hild ho s fa il  a e st uggli g al ead , al a s 
the first thing is getting the diabetes under 
control and everybody agrees and quite often 
it s led f o  the do to s the ll e like do t 
o  a out the glute  f ee diet  ut the  
that s a diffi ult situatio  he  late  do  the 
li e ou e t i g to the  e-engage with the 
fa il  a d o iousl  the e ell a a e that 
the do to  ki d of said do t thi k a out the 
glute  f ee diet  a d the e just a epted that 
poi t that the  do t ha e to follo  the glute  
free diet, its vey hard to then re-engage 
e ause the e got that essage that it s ot 
as strict. While with diabetes, we would always 
e ette  o t ol, ette  o t ol  a d the 
whole team give a much more consistent team 
essage. A d the e s a lot of esea h i  
diabetes that if the team give a consistent 
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 message you tend to have better compliance 
and control, and I thi k it s defi itel  fo  the 
oelia  disease if the e is t as u h of a tea  
message, it tends to be more to the dietician 
that is o sta tl  as the fa ilies ould sa  o  
at the  he eas the do to s ki d of lea e it to 
us to deal with that issue. Charlotte; 522-537 
 
But ith oelia  disease, I do t thi k the 
doctors have as much awareness and will 
p o a l  thi k oh the dieti ia  a  look at that 
fo  ou  a d so the e is t as u h so t of tea  
support and team consistency with the message 
with coeliac disease. 
Why do you think that is? 
Erm I think probably because we are the 
diabetes team and that is our main focus and a 
lot of our patients are picked up through 
screening so I guess we meet the family and the 
focus is on diabetes and then when they get the 
diagnosis of coeliac disease it is the dietician 
that tends to take the lead on that advice. So I 
think the doctors kind of always bounce it back 
to us e ause the  k o  e e the e pe ts a d 
the e s a ed of sa i g so ethi g o g. E  
so I do t thi k the  sa  a thi g… the  
ould t sa  a thi g o g, its just o e that 
the  do t feel o fide t ith the oelia  
disease to kind of give the answers, so they 
always bounce it back to us. Charlotte; 539-559 
 
We do a joint coeliac diabetic clinic and we 
have the gastroenterologist that comes, and the 
die etologist. We do a joi t li i  a d the e s a 
dietician as well. Erm, my experience from the 
li i , I do t feel that gast o- ise that the e s 
u h that the  do. I thi k it s the dieteti s 
that s the ost i po ta t, e ause e e the 
ones that can really help them to change and 
e ll p o a l  ha e the a s e s of ho  e a  
help them with the bits they are struggling. 
Whereas the medics are probably, if the tTGS 
a e aised the ll sa  e eed a diet e iew, so 
it will come back to us Mandy; 165-172 
 
we still kept it going because we felt it was 
really important for them to have that joint 
e ie . A d also it ea s the  do t eed to 
see the gastroenterologist separately and the 
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diabetes team separate, its o e thi g that s 
joi t. A d the  k o  e e thi ki g of oth 
o ditio s, its that essage to the  that e e 
sending, its not just your diabetes its your 
oelia  disease too that e e o e ed a out. 
Because from the diabetes team we kept that 
going, we did t de ide to ot o ti ue it. 
Mandy; 489-496 
 
If we can work together as a team and we all 
say the same thing, then hopefully at some 
poi t the fa ilies goi g to thi k ell the e all 
saying the same thing so there must be 
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